Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 168 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

Table of Contents
Year : 2012  |  Volume : 16  |  Issue : 7  |  Page : 27-36

Infections in patients with diabetes mellitus: A review of pathogenesis

Department of Pediatrics, Pediatric Endocrinology Unit, Hospital Universitario Prof. Edgard Santos, Faculty of Medicine, Federal University of Bahia, Salvador, Bahia, Brazil

Date of Web Publication24-Mar-2012

Correspondence Address:
Cresio Alves
Department of Pediatrics, Pediatric Endocrinology Unit, Hospital Universitário Prof. Edgard Santos, Faculty of Medicine, Federal University of Bahia, Rua Plínio Moscoso, 222/601, CEP: 40157-190, Salvador - Bahia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2230-8210.94253

Rights and Permissions

In general, infectious diseases are more frequent and/or serious in patients with diabetes mellitus, which potentially increases their morbimortality. The greater frequency of infections in diabetic patients is caused by the hyperglycemic environment that favors immune dysfunction (e.g., damage to the neutrophil function, depression of the antioxidant system, and humoral immunity), micro- and macro-angiopathies, neuropathy, decrease in the antibacterial activity of urine, gastrointestinal and urinary dysmotility, and greater number of medical interventions in these patients. The infections affect all organs and systems. Some of these problems are seen mostly in diabetic people, such as foot infections, malignant external otitis, rhinocerebral mucormycosis, and gangrenous cholecystitis. In addition to the increased morbidity, infectious processes may be the first manifestation of diabetes mellitus or the precipitating factors for complications inherent to the disease, such as diabetic ketoacidosis and hypoglycemia. Immunization with anti-pneumococcal and influenza vaccines is recommended to reduce hospitalizations, deaths, and medical expenses.

Keywords: Diabetes mellitus, immunization, infections, vaccines

How to cite this article:
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocr Metab 2012;16, Suppl S1:27-36

How to cite this URL:
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocr Metab [serial online] 2012 [cited 2021 Sep 27];16, Suppl S1:27-36. Available from: https://www.ijem.in/text.asp?2012/16/7/27/94253

   Introduction Top

Diabetes mellitus (DM) is a clinical syndrome associated with deficiency of insulin secretion or action. It is considered one of the largest emerging threats to health in the 21 st century. It is estimated that there will be 380 million persons with DM in 2025. [1] Besides the classical complications of the disease, DM has been associated with reduced response of T cells, neutrophil function, and disorders of humoral immunity. [2],[3],[4] Consequently, DM increases the susceptibility to infections, both the most common ones as well as those that almost always affect only people with DM (e.g. rhinocerebral mucormycosis). [4] Such infections, in addition to the repercussions associated with its infectivity, may trigger DM complications such as hypoglycemia and ketoacidosis.

This article aims to critically review the current knowledge on the mechanisms associated with the greater susceptibility of DM for developing infectious diseases and to describe the main infectious diseases associated with this metabolic disorder.

   Materials and Methods Top

The MEDLINE and LILACS databases were searched for articles published between 1999 and 2011, using the following keywords in various combinations: "diabetes mellitus," "infections," "immunization," and "vaccines." Bibliographic search included consensus papers, editorials, original articles, and review articles written in English, Spanish, and Portuguese. The articles were initially selected on the basis of their titles and abstracts. Articles published in languages other than the selected ones, articles without abstract, and those articles whose titles were not relevant to the purpose of this review were excluded.

   Diabetes Mellitus and Infections: Physiopathology Top

The main mechanisms associated with the interface DM and infections are depicted in [Figure 1].
Figure 1: Pathophysiology of infections associated with diabetes millitus

Click here to view


The complement system is one of the main mechanisms responsible for the humoral immunity. It consists of serum and surface proteins whose main functions are to promote the opsonization and phagocytosis of microorganisms through macrophages and neutrophils and to induce the lysis of these microorganisms. Moreover, complement activation products provide the second signal for B-lymphocyte activation and antibody production.

Although some studies have detected a deficiency of the C4 component in DM, [5],[6] this reduction of C4 is probably associated with polymorphonuclear dysfunction and reduced cytokine response. [2],[5]

Inflammatory cytokines

Mononuclear cells and monocytes of persons with DM secrete less interleukin-1 (IL-1) and IL-6 in response to stimulation by lipopolysaccharides. [2],[4] It appears that the low production of interleukins is a consequence of an intrinsic defect in the cells of individuals with DM. [2],[7] However, other studies reported that the increased glycation could inhibit the production of IL-10 by myeloid cells, as well as that of interferon gamma (IFN-γ) and tumor necrosis factor (TNF)-α by T cells. Glycation would also reduce the expression of class I major histocompatibility complex (MHC) on the surface of myeloid cells, impairing cell immunity. [8]

Polymorphonuclear and mononuclear leukocytes

Decreased mobilization of polymorphonuclear leukocytes, chemotaxis, and phagocytic activity may occur during hyperglycemia. [4],[9],[10] The hyperglycemic environment also blocks the antimicrobial function by inhibiting glucose-6-phosphate dehydrogenase (G6PD), increasing apoptosis of polymorphonuclear leukocytes, and reducing polymorphonuclear leukocyte transmigration through the endothelium. [4] In tissues that do not need insulin for glucose transport, the hyperglycemic environment increases intracellular glucose levels, which are then metabolized, using NADPH as a cofactor. The decrease in the levels of NADPH prevents the regeneration of molecules that play a key role in antioxidant mechanisms of the cell, thereby increasing the susceptibility to oxidative stress.

Regarding the mononuclear lymphocytes, some studies had demonstrated that when the glycated hemoglobin (HbA1c) is <8.0%, the proliferative function of CD4 T lymphocytes and their response to antigens is not impaired. [4]


Glycation of immunoglobulin occurs in patients with diabetes in proportion with the increase in HbA1c, and this may harm the biological function of the antibodies. [4] However, the clinical relevance of these observations is not clear, since the response of antibodies after vaccination and to common infections is adequate in persons with DM. [4]

   Major Infections Associated with Diabetes Mellitus Top

Some investigators claim that the differences in the risk factors for infection between diabetic and non-diabetic patients result either from non-controlled studies or biased studies (e.g. persons with DM have frequent medical appointments which may increase the probability of being diagnosed with other diseases). However, most researchers conclude that there is clinical evidence pointing to the higher prevalence of infectious diseases among individuals with DM. [2],[3],[10] [Table 1] summarizes the major infections associated with DM.
Table 1: Major infections associated with diabetes mellitus

Click here to view

Respiratory infections

Respiratory tract infections are responsible for a significant number of medical appointments by persons with DM compared to those without DM. [4],[11],[12],[13],[14],[15],[16]

Streptococcus pneumoniae and influenza virus

The most frequent respiratory infections associated with DM are caused by Streptococcus pneumoniae and influenza virus. [9],[15] Persons with DM six times more likely need hospitalization during influenza epidemics than non-diabetic patients. [4] Diabetes is also a common coexisting condition and a risk factor for complications in patients with H1N1 (pandemic influenza virus) infection. [17]

The American Diabetes Association (ADA) [11] and the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) [13] recommend anti-pneumococcal and influenza vaccination for people with DM, as shown in [Table 2] and [Table 3], respectively. The World Health Organization recommends vaccination against the H1N1 virus, which is a single-dose vaccine, to minimize the virus-related morbidity and mortality. [18]
Table 2: Influenza vaccination in patients with diabetes mellitus[11],[12],[13]

Click here to view
Table 3: Pneumococcal vaccination in patients with diabetes mellitus[11],[12],[13]

Click here to view

These vaccines reduce the number of respiratory infections, the number and length of hospitalizations, the deaths caused by respiratory tract infections, and the medical expenses related to influenza and pneumonia. [15] Despite these benefits, the vaccination coverage in persons with DM remains inadequate. [19],[20]


In 2009, approximately 9 million new cases of tuberculosis were diagnosed and 1.7 million persons died from this infection. [21] Patients with diabetes are at higher risk of contracting tuberculosis than individuals without DM. [21,22] Some studies have reported that persons with DM are more likely to develop multi-resistant tuberculosis and that treatment failures and death are more frequent in these patients. [23] In addition, tuberculosis infection and treatment (rifampicin increasing the metabolism of oral antidiabetic drugs) may complicate the glycemic control. [24]

It is suggested that DM depresses the immune response (impairing chemotaxis, phagocytosis, and antigen presentation in response to Mycobacterium tuberculosis infection and affecting T-cell function and proliferation) facilitating infection and progression to symptomatic disease. [21],[22],[23]

The association of these two diseases poses a major burden to the health public system, especially in the developing countries where tuberculosis is one of the most important causes of bacterial infection and the prevalence of type 2 DM is increasing. Therefore, routine screening of patients with tuberculosis for DM and patients with DM for tuberculosis should be implemented.

Urinary infections

Urinary tract infections (UTIs) are more prevalent in individuals with DM and may evolve to complications and/or serious manifestations. [25],[26],[27] The main risk factors for UTI in DM are: inadequate glycemic control, duration of DM, diabetic microangiopathy, impaired leukocyte function, recurrent vaginitis, and anatomical and functional abnormalities of the urinary tract. [4],[25],[26],[27],[28],[29]

Asymptomatic bacteriuria

Although women with DM have greater prevalence of asymptomatic bacteriuria, [25],[27],[28],[29],[30] the data on the natural history of this condition in women with DM are conflicting. Some studies reported progression to pyelonephritis, [28],[30] whereas other suggested that this does not lead to serious complications. [11],[25],[31] Thus, the routine recommendation of antibiotic therapy for asymptomatic bacteriuria in diabetic women remains controversial. [16]

Bacterial pyelonephritis

Acute pyelonephritis is 4-5 times more common in individuals with DM. [26] Most infections are caused by  Escherichia More Details coli or Proteus sp. [9] The clinical presentation is similar to that of non-diabetic individuals, except for the bilateral renal involvement. [4],[32] Additionally, persons with DM are at increased risk for complications such as perinephric and/or renal abscesses, emphysematous pyelonephritis (EP), and renal papillary necrosis. [4],[9],[32]

Emphysematous pyelonephritis

EP is characterized by necrosis of the renal parenchyma with the presence of gas in the collecting system or in the perinephric tissues. [30],[31],[32],[33],[34],[35],[36] It is most commonly observed in DM women. [16],[25],[32],[33],[34],[35],[36]

E. coli and Enterobacter aerogenes are the most frequent pathogens, followed by Klebsiella sp., Proteus sp., Candida and Streptococcus sp. [9],[32],[33]

Fever, chills, mass and flank pain, nausea, and vomiting are the first symptoms. [27] Crackles in the flank or thigh are less frequent. [16],[32],[35],[37] Abdominal computerized tomography allows the identification of gas in the urinary tract. [9],[16],[32],[33],[38],[39],[40]

Fungal cystitis

Fungal infections are more common in DM, particularly those caused by Candida.[28],[41] The distinction between infection and colonization can be difficult. The presence of urinary symptoms or pyuria suggests infection. [9] Fungal cystitis may result in the formation of "fungal balls" which may complicate as urinary tract obstruction. [28]

Emphysematous cystitis

Emphysematous cystitis affects persons with DM more frequently than non-diabetics. [26],[40],[42],[43] It is characterized by the presence of gas in the bladder cavity and infiltration of the bladder wall due to infection by bacteria that produce carbon dioxide. [44] The most frequent pathogen is E. coli, followed by Enterobacter, Proteus, Klebsiella, and Candida. [32] Women are more affected than men. [26],[40],[44] Computerized tomography is the standard diagnostic method. [42]

Perinephric abscess

The main etiologies of renal and perinephric abscesses are enteric gram-negative bacilli (predominantly E. coli) or polymicrobial infection. [45],[46],[47] Around one-third of perinephric abscesses occur in persons with DM. [16],[46],[47]

The initial clinical manifestations are fever, backache, dysuria, and/or polyuria. [47] A palpable mass may be present. [42] In case of perirenal suppuration, the overlying skin may show inflammatory reaction. [48] In individuals with DM, the clinical presentation is non-specific. Therefore, the diagnosis is usually late, contributing to worse prognosis. This diagnosis should be considered in patients with acute pyelonephritis that does not get better after antimicrobial therapy. [45]

Gastrointestinal and liver infections

The regularity of gastrointestinal motility and sensitivity are important mechanisms of defense against infections. [32] Chronic hyperglycemia contributes to increase the risk of gastrointestinal infectious processes. [32],[49]

Gastritis caused by Helicobater pylori

The association of DM and infection by Helicobacter pylori is controversial. Although some studies showed that some virulent strains of H. pylori are related to macroangiopathy, neuropathy, and microalbuminuria in patients with DM2, there is apparently no relationship between H. pylori infection and these DM complications. [49],[50],[51],[52],[53]

Some data indicate a possible association of H. pylori infection with coronary insufficiency and/or cerebral occlusive vascular disease in adults with DM. [51] Another consequence of this infection is the increase in insulin requirements in children with DM1. [51]

The efficiency of H. pylori eradication is lower in persons with DM, whereas the re-infection rates are seen to be higher. [50],[51],[54]

Oral and esophageal candidiasis

The most common etiological agent is Candida albicans. [4],[55] Its pathogenesis is related to a combination of factors that increase its virulence, with emphasis on the production of extracellular enzymes such as proteinase and phospholipase. [55] Candidiasis manifests in different ways: median rhomboid glossitis or central papillary atrophy, atrophic glossitis, denture stomatitis, pseudomembranous candidiasis, and angular cheilitis. [55] The diagnosis is eminently clinical. However, in case of esophageal candidiasis, endoscopy is needed. [55]

Emphysematous cholecystitis

The emphysematous cholecystitis is more frequent in males with DM. [32] The main pathogens are  Salmonella More Details enteritidis and Campylobacter.[32] The clinical presentation is not different from that of non-complicated cholecystitis (e.g. right upper quadrant abdominal pain, vomiting, and fever). [9] Clinical signs of peritonitis are usually not observed. Crackles can be felt on abdominal palpation, being associated with a worse prognosis. [9] The diagnosis is made by the detection of gas inside the gall bladder, demonstrated in radiograph or computerized tomography scan. [32]

Hepatitis C

Hepatitis C virus (HCV) is a major public health problem affecting more than 170 million people worldwide and this figure is expected to increase due the lack of a vaccine to prevent it. [56] Approximately 50-80% of these patients develop a chronic infection and have a greater chance to progress to cirrhosis.

Several studies, from different countries, have reported that 13-33% of patients with HCV infection have diabetes, mostly type 2 diabetes mellitus (T2DM), [57] compared with the prevalence of 4-10% for non-HCV control population. [58] These data suggest that patients with HCV are 3 times more likely to develop DM than individuals who are HCV negative. Therefore, T2DM is considered an extrahepatic manifestation of this infection. [57]

Patients with HCV who develop T2DM have a more severe liver disease and increased fibrosis compared to non-diabetic HCV patients. [59] Possible explanations are that in individuals with a genetic predisposition to T2DM, the HCV infection could cause (1) impairment of beta-cell responsiveness as a result of a direct viral effect, mostly the genotype 1 or 4, [60] and/or (2) liver damage leading to an abnormal glucose metabolism and insulin resistance. [57]

Early screening for T2DM should be instituted in all patients with HCV, especially if they have other risk factors for diabetes, and screening for T2DM should be performed in areas of high HCV prevalence.

Hepatitis B

About 350 million people are infected by the hepatitis B virus (HBV) worldwide. [60] This number is expected to decrease with the availability and widespread use of the anti-HBV vaccine.

The studies on the relationship between HBV and T2DM are not consistent. Some investigators have reported blood glucose abnormalities, [61] while others have not. [62] Lao et al. [63] reported an independent association between HBV infection and gestational diabetes. Further studies are needed to clarify this questionable association.

However, HBV infection outbreaks have been reported among diabetic patients who share a blood glucose meter without cleaning and disinfecting between uses, associated with limited awareness of the high risk for HBV transmission during fingerstick blood glucose monitoring. [64]


Enteroviruses are largely distributed in the world and are mainly transmitted by the fecal-oral route. They are classified into five species: poliovirus, human enterovirus A, human enterovirus B (including the six Coxsackie B virus serotypes), echovirus C, and echovirus D.

Several epidemiological and clinical studies have supported the role of enterovirus, especially Coxsackie B4 and B3 virus, in the development of T1DM in genetically predisposed individuals. [6] Such association is supported by the description of a temporal relationship between the occurrence of T1DM and peaks of enterovirus infections and by the detection of anti-enterovius antibodies, enterovirus RNA, and capsid protein VP1 in blood, small intestine biopsies, and autopsy pancreas specimens of individuals with T1DM. [65]

Various mechanisms can explain the role of enterovirus in the pathogenesis of T1DM: [65],[66] (1) persistent infection of pancreatic beta cells provoking cell damage and release of sequestered antigens inducing an autoimmune response; (2) molecular mimicry (partial sequence homology) between the 2C viral protease and the GAD65 (Glutamic Acid Descarboxilase) and between the VP1 viral capsid protein and the IA2 protein; (3) bystander activation of autoreactive T cells; (4) thymus infection; and (5) loss of regulatory T cells. However, a causative correlation still needs to be established.

Skin and soft tissue infection

Persons with DM are more predisposed to skin and soft tissue infections such as folliculitis, furunculosis, and subcutaneous abscesses. These infections may break out during the course of the disease or may be the first sign of DM presentation, [67],[68] and can also be more severe in these populations. [4],[32],[67]

Foot infection

Foot infections are the most important chronic complications of DM, being one of the most common causes of hospitalization and often resulting in amputation, osteomyelitis, and death. [4],[9],[67],[69],[70]

The clinical signs of infections are very protean and poor, often leading to delayed diagnosis. [71] The diabetic foot infections are usually divided into moderate or "non-limb threatening" and serious or "limb-threatening." [32],[70],[72] Moderate infections are defined as superficial, with cellulitis less than 2.0 cm in the largest diameter, without evidence of serious ischemia, systemic toxicity, or bone and/or articular involvement. Serious infections are defined as deep ulceration, with celullitis equal to or greater than 2.0 cm in the largest diameter, with evidence of serious ischemia, systemic toxicity, or bone and/or joint involvement. [72]

These infections can be monomicrobial or polymicrobial. Staphylococcus aureus and Staphylococcus epidermidis are isolated from around 60% of all the infected ulcers. Enterococci, streptococci, and enterobacteria are less frequent, and 15% of the infected ulcers have strict anaerobic bacteria. [70]

Infection in a very recently acquired superficial ulcer is likely to be monomicrobial due to aerobic Gram-positive cocci, such as staphylococci, while a long duration of ulceration and increased depth are likely to increase the chances of the wound, yielding both polymicrobial growth and resistant organisms. [70]

Simple clinical assessments are predictive of bone involvement, such as size and depth of ulcer. Ulcers larger or deeper than 2 cm2 are more likely to be associated with underlying bone infection. [16],[32],[71] It is worth stressing that imaging evaluation can be normal in the beginning of the infection, since radiological abnormalities are either observed 10-20 days after the beginning of the infectious process or when 40-70% of the bone is lost. [16],[32] Thus, the most sensitive tests are scintigraphy and magnetic resonance imaging. [16]

Necrotizing fasciitis

Necrotizing fasciitis is characterized by fast and progressive necrosis of the fascia and subcutaneous tissue, causing fulminant local tissue destruction, microvascular thrombosis, and systemic signs of toxicity. Mortality occurs in approximately 40% of the cases. [9],[73],[74],[75],[76]

The initial symptoms are fever and intense local pain, followed by areas of skin necrosis with small ulcers that drain a colorless fluid and have unpleasant smell. [16],[32] Air in the soft tissues can be better detected by radiograph. [32] The most affected sites are thorax, abdominal wall, extremities, perineum, and groin. [74],[75],[76]

In DM, fasciitis is typically polymicrobial, with one anaerobic and many aerobic microorganisms. [16] Type I fasciitis is caused by the combination of an anaerobic microorganism with one or more facultative aerobic microorganisms, and type II fasciitis is caused by a group A streptococcus with or without the involvement of staphylococci. [75],[76]

Fournier gangrene

Fournier gangrene is a fasciitis that affects the male genitalia. The most common etiologic agents are E. coli, Klebsiella sp., Proteus sp., and Peptostreptococcus.[77],[78] The etiology can also be polymicrobial, involving Clostridium, aerobic or anaerobic streptococci, and Bacteroides.[32],[78]

Up to 70% of the patients with this infection have DM. [29],[32],[77] It usually involves the scrotum, but can be extend to the penis, perineum, and abdominal wall. [9],[16],[29],[78] Contrary to the general belief, the testicles are usually spared. [77]

Head and neck infections

The two most serious head and neck infections in diabetic persons are invasive external otitis and rhinocerebral mucormycosis. [32]

Invasive external otitis

Invasive external otitis is an infection of the external auditory canal that can extend to the skull base and adjacent regions. [9],[16],[79] It often affects elderly diabetic individuals and the etiologic agent is usually Pseudomonas aeruginosa.[16],[79]

Excruciating pain, otorrhea, and hearing loss are the characteristics. [9] Skull base osteomyelitis and cranial nerve involvement may occur. Facial paralysis occurs in 50% of the cases. [16] The best diagnostic method is the magnetic resonance imaging. [16]

Rhinocerebral mucormycosis

Mucormycosis is a rare opportunistic and invasive infection caused by fungi of the class Zygomycetes. [80],[81] The genus most commonly associated with human infections is the Rhizopus, followed by Mucor and Cunninghamella.[82]

This infection occurs in approximately 50% of the cases in individuals with DM due to the greater availability of glucose to the pathogen that causes mucormycosis, the decrease in serum inhibitory activity against the Rhizopus in lower pH, and the increased expression of some host receptors that mediate the invasion and damage to human epithelial cells by Rhizopus.[32],[79],[83]

The mucormycosis can be acute and chronic. [80],[81],[82] The classical triad is characterized by paranasal sinusitis, ophthalmoplegia with blindness, and unilateral proptosis with cellulitis. [16],[80] Facial or eye pain and necrotic wound of the palate of the nasal mucosa may occur. Black necrotic eschar in the nasal cornets is a characteristic sign. [16],[85],[82]


Periodontitis is a chronic inflammatory disease characterized by the formation of a periodontal pocket, loss of connective tissue, and alveolar bone resorption, which may sometimes result in tooth loss. It is four times more common in persons with DM and is considered the sixth most common complication of DM. [4],[84],[85] Periodontitis starts or disseminates insulin resistance, thus worsening glycemic control. [4],[16],[84],[85],[86] Inversely, persistent poor glycemic control has been associated with a greater incidence and progression of gingivitis and periodontitis, producing a vicious circle. [4],[85],[86]

Many mechanisms have been proposed to explain the increased susceptibility to periodontal disease in these patients, such as alterations in immune response, subgingival microbiota aspects, altered collagen metabolism, alteration in oral vascularization, hereditary patterns, altered neutrophil function, reduced phagocytic capacity, and chemotaxis. [4],[5],[6],[7],[8],[9],[10],[11],[12],[13],[14],[15],[16],[17],[18],[19],[20],[21],[22],[23],[24],[25],[26],[27],[28],[29],[30],[31],[32],[33],[34],[35],[36],[37],[38],[39],[40],[41],[42],[43],[44],[45],[46],[47],[48],[49],[50],[51],[52],[53],[54],[55],[56],[57],[58],[59],[60],[61],[62],[63],[64],[65],[66],[67],[68],[69],[70],[71],[72],[73],[74],[75],[76],[77],[78],[79],[80],[81],[82],[83],[84]

Other infections

Human immunodeficiency virus

Approximately 33 million people were infected by the human immunodeficiency virus (HIV) in 2007. [87] The improvements in diagnosis and treatment have translated into an increasing number of patients developing chronic complications including DM.

The increased risk of developing diabetes is related to the HIV itself or its treatment. [88] Insulin resistance is the main mechanism implicated in the pathogenesis of diabetes in HIV patients. [87] Insulin resistance results from high levels of inflammatory cytokines that impair glucose tolerance, leading to the development of T2DM. More recently, some patients were reported to develop autoimmune T1DM after immune restoration during highly active antiretroviral therapy (HAART). [89]

Risk factors for DM in HIV patients are: high viral burden, low CD4 count, longer duration of HIV infection, advancing age, male gender, lower socioeconomic class, and accumulation of visceral fat. [87]

Diabetes is fourfold more frequent in HIV patients on HAART. [89] The protease inhibitors cause insulin resistance by interfering with the GLUT-4 mediated transport and by inhibiting the peroxisomal proliferator activated receptor which increases the release of fatty acids and induces insulin resistance. The nucleoside reverse transcriptase inhibitors also contribute to the insulin resistance.

Patients with HIV should be screened for diabetes at diagnosis, at the onset, and during HAART therapy. An oral glucose tolerance test is recommended to assess the insulin resistance. The treatment of DM in HIV poses some limitations. For example, although metformin is the drug of choice, its use may not be tolerated by cachexic patients or by those with lypoatrophy. The side effects of thiazolidinediones (e.g. higher cardiovascular morbidity, osteoporosis) may prevent their use in HIV patients with diabetes. Glinides and sulfonylureas may not be effective due to insulin resistance. [87] Therefore, insulin is the drug of choice for the HIV-associated diabetes.

Other viruses

T1DM has been associated with other viral infections including rubella, mumps, Epstein-Barr and cytomegalovirus. The viral infection usually precedes the clinical presentation of T1DM. The causality between enterovirus infections and the diabetogenic proocess are still unclear. [90]

   Conclusions Top

Infectious diseases are more prevalent in individuals with DM. The main pathogenic mechanisms are: hyperglycemic environment increasing the virulence of some pathogens; lower production of interleukins in response to infection; reduced chemotaxis and phagocytic activity, immobilization of polymorphonuclear leukocytes; glycosuria, gastrointestinal and urinary dysmotility. Some infections almost always affect only diabetic persons, such as malignant external otitis, rhinocerebral mucormycosis, and gangrenous cholecystitis. In addition to being potentially more serious, infectious diseases in DM may result in metabolic complications such as hypoglycemia, ketoacidosis, and coma. The recommendation of compulsory immunization with anti-pneumococcal and influenza vaccines is essential because of their impact on the reduction of respiratory infections, the number and length of hospitalizations and the number of deaths related to respiratory tract diseases.

More research is needed for clarification of the immunopathogenic mechanisms linking DM and infections and to develop strategies to improve vaccination coverage for diabetic patients.

   References Top

1.Atkins RC, Zimmet P. Diabetic kidney disease: Act now or pay later. Saudi J Kidney Dis Transpl 2010;21:217-21.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999;26:256-65.  Back to cited text no. 2
3.Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281-8.  Back to cited text no. 3
4.Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: Pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007;23:3-13.  Back to cited text no. 4
5.Stoeckle M, Kaech C, Trampuz A, Zimmerli W. The role of diabetes mellitus in patients with bloodstream infections. Swiss Med Wkly 2008;138:512-9.  Back to cited text no. 5
6.Flyvbjerg A. Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. Nat Rev Endocrinol 2010;6:94-101.  Back to cited text no. 6
7.Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 2000;30:995-1001.  Back to cited text no. 7
8.Price CL, Al Hassi HO, English NR, Blakemore AI, Stagg AJ, Knight SC. Methylglyoxal modulates immune responses: relevance to diabetes. J Cell Mol Med 2010;14:1806-15.   Back to cited text no. 8
9.Nirmal J, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999;341:1906-12.  Back to cited text no. 9
10.Vardakas KZ, Siempos II, Falagas ME. Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality. Diabet Med 2007;24:1168-71.  Back to cited text no. 10
11.American Diabetes Association (ADA). Standards of medical care in diabetes-2011. Diabetes Care 2011;33:S11-61.  Back to cited text no. 11
12.Cano M, Iglesias P, Pérez G, Díez JJ. Influenza A virus (H1N1) infection as a cause of severe diabetic ketoacidosis in type 1 diabetes. Endocrinol Nutr 2010;57:37-8.  Back to cited text no. 12
13.Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). The Pink Book: Chapters Epidemiology and Prevention of Vaccine Preventable Diseases. 12 th Edition, April 2011. Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/pink-chapters.htm [Last Accessed on 2011 Oct 12].   Back to cited text no. 13
14.Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Type 2 diabetes and pneumonia outcomes: A population-based cohort study. Diabetes Care 2007;30:2251-7.  Back to cited text no. 14
15.Barros MM, Cartagena SC, Bavestrello FL. Prevention of community-acquired pneumonia in adults. Rev Chilena Infectol 2005;22:s67-74.  Back to cited text no. 15
16.Rocha J, Baggio H, Cunha C, Niclewicz E, Leite S, Baptista M. Aspectos relevantes da interface entre diabetes mellitus e infecção. Arq Bras Endocrinol Metab 2002;46:221-9.  Back to cited text no. 16
17.Miller AC, Subranian RA, Safi F, Sinert R, Zehtabchi S, Elamin EM. Influenza A 2009 (H1N1) virus in admitted and critically ill patients. J Intensive Care Med 2011;27:25-31.  Back to cited text no. 17
18.Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44.  Back to cited text no. 18
19.Aubert C, Vaudaux B, Bart PA. Immunization guidelines regarding patients with a chronic disease. Rev Med Suisse 2010;6:798-803.  Back to cited text no. 19
20.Giannattasio A, Squeglia V, Lo Vecchio A, Russo MT, Barbarino A, Carlomagno R, et al. Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions. Ital J Pediatr 2010;36:28.  Back to cited text no. 20
21.Restrepo BI, Camerlin AJ, Rahbar MH, Wang W, Restrepo MA, Zarate I, et al. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bull World Health Organ 2011;89:352-9.  Back to cited text no. 21
22.Harries AD, Lin Y, Satyanarayana S, Lönroth K, Li L, Wilson N, et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from the HIV-associated tuberculosis. Inter J Tuberc Lung Dis 2011;15:1436-45.  Back to cited text no. 22
23.Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: Convergence of two epidemics. Lancet Infect Dis 2009;9:737-46.  Back to cited text no. 23
24.Ruslami R, Aarniutse RE, Alisjahbana B, van der Ven AJ, van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health 2010;15:1289-99.  Back to cited text no. 24
25.Geerlings SE. Urinary tract infections in patients with diabetes mellitus: Epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 2008;31S:S54-7.  Back to cited text no. 25
26.Ludwig E. Urinary tract infections in diabetes mellitus. Orv Hetil 2008;149:597-600.  Back to cited text no. 26
27.Hokkam EN. Assessment of risk factors in diabetic foot ulceration and their impact on the outcome of the disease. Prim Care Diab 2009;3:219-24.  Back to cited text no. 27
28.Stapleton A. Urinary tract infections in patients with diabetes. Am J Med 2002;113:80S-4S.  Back to cited text no. 28
29.Chen SL, Jackson SL, Boyko EJ. Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models. J Urol 2009;182:S51-6.  Back to cited text no. 29
30.Papazafiropoulou A, Daniil I, Sotiropoulos A, Balampani E, Kokolaki A, Bousboulas S, et al. Prevalence of asymptomatic bacteriuria in type 2 diabetic subjects with and without microalbuminuria. BMC Res Notes 2010;3:169.  Back to cited text no. 30
31.Meiland R, Geerlings SE, Stolk RP, Netten PM, Schneeberger P, Hoepelman AI. Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of follow-up. Arch Intern Med 2006;166:2222-7.  Back to cited text no. 31
32.Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am 2001;15:407-20.  Back to cited text no. 32
33.Krishnasamy PV, Liby C. Emphysematous pyelonephritis caused by Candida tropicalis. Am J Med 2010;123:e7-8.  Back to cited text no. 33
34.Mokabberi R, Ravakhah K. Emphysematous urinary tract infections: diagnosis, treatment and survival (case review series). Am J Med Sci 2007;333:111-6.  Back to cited text no. 34
35.Mohsin N, Budruddin M, Lala S, Al-Taie S. Emphysematous pyelonephritis: a case report series of four patients with review of literature. Ren Fail 2009;31:597-601.  Back to cited text no. 35
36.Pontin AR, Barnes RD. Current management of emphysematous pyelonephritis. Nat Rev Urol 2009;6:272-9.  Back to cited text no. 36
37.Yao J, Gutierrez OM, Reiser J. Emphysematous pyelonephritis. Kidney Int 2007;71:462-5.  Back to cited text no. 37
38.Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II. Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol 2007;178:880-5.  Back to cited text no. 38
39.Solak Y, Turkmen K, Atalay H, Turk S. Culture-negative bilateral emphysematous pyelonephritis presented as acute renal failure and managed medically only. South Med J 2010;103:154-5.  Back to cited text no. 39
40.Thomas AA, Lane BR, Thomas AZ, Remer EM, Campbell SC, Shoskes DA. Emphysematous cystitis: A review of 135 cases. BJU Int 2007;100:17-20.  Back to cited text no. 40
41.Etienne M, Caron F. Management of fungal urinary tract infections. Presse Med 2007;36(12 Pt 3):1899-906.  Back to cited text no. 41
42.Grupper M, Kravtsov A, Potasman I. Emphysematous cystitis: illustrative case report and review of the literature. Medicine 2007;86:47-53.  Back to cited text no. 42
43.Kelesidis T, Osman S, Tsiodras S. Emphysematous cystitis in the absence of known risk factors: An unusual clinical entity. South Med J 2009;102:942-6.  Back to cited text no. 43
44.Baena JF, Romeu JP, Llopis JA, Tamayo AL, Encinas JJ. Emphysematous cystitis. Case report and review of literature. Actas Urol Esp 2008;32:948-50.  Back to cited text no. 44
45.Fullá J, Storme O, Fica A, Varas MA, Flores J, Marchant F, et al. Renal and perinephric abscesses: A series of 44 cases. Rev Chilena Infectol 2009;26:445-51.  Back to cited text no. 45
46.Coelho RF, Schneider-Monteiro ED, Mesquita JL, Mazzucchi E, Marmo Lucon A, Srougi M. Renal and perinephric abscesses: analysis of 65 consecutive cases. World J Surg 2007;31:431-6.  Back to cited text no. 46
47.Maldonado-Alcaraz E, Ixquiac-Pineda G, López-Sámano V, Serrano-Brambila E. Perinephric abscess: Associated factors and mortality. Arch Esp Urol 2008;61:7-12.  Back to cited text no. 47
48.Tsukagoshi D, Dinkovski B, Dasan S, Jethwa J. Perinephric abscess secondary to a staghorn calculus presenting as a subcutaneous abscess. CJEM 2006;8:285-8.  Back to cited text no. 48
49.Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001;24:371-81.  Back to cited text no. 49
50.Schimke K, Chubb SA, Davis WA, Philipst P, Davis TM. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: The fremantle diabetes study. Diabet Med 2009;26:70-5.  Back to cited text no. 50
51.Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ. Helicobacter pylori infection and endocrine disorders: is there a link?. World J Gastroenterol 2009;15:2701-7.  Back to cited text no. 51
52.Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009;14:144-50.  Back to cited text no. 52
53.Candelli M, Rigante D, Marietti G, Nista EC, Crea F, Bartolozzi F, et al. Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatrics 2003;111(4 Pt 1):800-3.  Back to cited text no. 53
54.Ojetti V, Pellicano R, Fagoonee S, Migneco A, Berrutti M, Gasbarrini A. Helicobacter pylori infection and diabetes. Minerva Med 2010;101:115-9.  Back to cited text no. 54
55.Menezes EA, Augusto KL, Freire CC, Cunha FA, Montenegro RM, Montenegro-Júnior RM. Frequency and enzymatic activity of Candida spp. oral cavity of diabetic patients of the service of endocrinology of a hospital of Fortaleza-CE. J Bras Patol Med Lab 2007;43:241-4.  Back to cited text no. 55
56.Jadoon NA, Shahzad MA, Yaqoob R, Hussain M, Ali N. Seroprevalence of hepatitis C in type 2 diabetes: Evidence for a positive association. Virol J 2010;7:304.  Back to cited text no. 56
57.Elhawary EI, Mahmoud GF, El-Daly MA, Mekky FA, Esmat GG, Abdel-Hamid M. Association of UVV with diabetes mellitus: an Egyptian case-control study. Virol J 2011;8:367.  Back to cited text no. 57
58.Negro F, Alaei M. Hepatitis C virus and type2 diabetes. World J Gastroenterol 2009;15:1357-47.  Back to cited text no. 58
59.Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M. Risk factors for diabetes mellitus and insulin resistance in chronic hepatitis C. J Hepatology 2001;35:279-83.  Back to cited text no. 59
60.Gutiérrez-Grobe Y, Ponciano-Rodriguez G, Méndez-Sanchez N. Viral hepatitis infection and insulin resistance: A review of pathophysiological mechanisms. Salud Pub Mex 2010;53:S46-51.  Back to cited text no. 60
61.Demir M, Serin E, Göktürk S, Ozturk NA, Kulaksizoglu S, Ylmaz U. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients. Eu J Gastroenterol Hepatol 2008;20:668-73.  Back to cited text no. 61
62.Huang ZS, Huang TS, Wu TH, Chen MF, Hsu CS, Kai JH. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation. J Gastroenterol Hepatol 2010;25:1420-5.  Back to cited text no. 62
63.Lao TT, Chan BC, Leung WC, Ho LF, Tse KY. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol 2007;47:46-50.  Back to cited text no. 63
64.Thomson ND, Perz JF. Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol 2009;3:283-8.  Back to cited text no. 64
65.Hober D. Enteroviral pathogenesis of type 1 diabetes. Discov Med 2010;10:151-60.  Back to cited text no. 65
66.Stene LC, Oikarinen S, Hyöty H, Barriga KJ, Norris JM, Klingensmith G, et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes. The Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010;59:3174-80.  Back to cited text no. 66
67.Lipsky BA, Tabak YP, Johannes RS, Vo L, Hyde L, Weigelt JA. Skin and soft tissue infections in hospitalized patients with diabetes: Culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 2010;53:914-23.  Back to cited text no. 67
68.Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol 2006;24:237-46.  Back to cited text no. 68
69.Fincke BG, Miller DR, Christiansen CL, Turpin RS. Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study. BMC Health Serv Res 2010;10:193.  Back to cited text no. 69
70.Nicolau DP, Stein GE. Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics. J Am Podiatr Med Assoc 2010;100:52-63.  Back to cited text no. 70
71.Powlson AS, Coll AP. The treatment of diabetic foot infections. J Antimicrob Chemother 2010;65 Suppl 3:iii3-9.  Back to cited text no. 71
72.Joseph WS, Lipsky BA. Medical therapy of diabetic foot infections. J Vasc Surg 2010;52 Suppl 3:67S-71.  Back to cited text no. 72
73.Zhang WJ, Cai XY, Yang C, Zhou LN, Cai M, Lu XF, et al. Cervical necrotizing fasciitis due to methicillin-resistant Staphylococcus aureus: A case report. Int J Oral Maxillofac Surg 2010;39-830-4.  Back to cited text no. 73
74.Oguz H, Demirci M, Arslan N, Safak MA, Paksoy G. Necrotizing fasciitis of the head and neck: Report of two cases and literature review. Ear Nose Throat J 2010;89:E7-10.  Back to cited text no. 74
75.Shaikh N, Ummunissa F, Hanssen Y, Al Makki H, Shokr HM. Hospital epidemiology of emergent cervical necrotizing fasciitis. J Emerg Trauma Shock 2010;3:123-5.  Back to cited text no. 75
[PUBMED]  Medknow Journal  
76.Shimizu T, Tokuda Y. Necrotizing fasciitis. Intern Med J 2010;49:1051-7.  Back to cited text no. 76
77.Tran HA, Hart AM. Fournier's gangrene. Intern Med J 2006;36:200-1.  Back to cited text no. 77
78.Montoya Chinchilla R, Izquierdo Morejon E, Nicolae Pietricicâ B, Pellicer Franco E, Aguayo Albasini JL, Miñana López B. Fournier's gangrene. Descriptive analysis of 20 cases and literature review. Actas Urol Esp 2009;33:873-80.  Back to cited text no. 78
79.Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am 2008;41:537-49.  Back to cited text no. 79
80.Artal R, Agreda B, Serrano E, Alfonso JI, Vallés H. Rhinocerebral mucormycosis: Report on eight cases. Acta Otorrinolaringol Esp 2010;61:301-5.  Back to cited text no. 80
81.Giuliani A, Mettimano M, Viviani D, Scagliusi A, Bruno A, Russo A, et al. An uncommon case of systemic mucormycosis associated with spinal cord infarction in a recently diagnosed diabetic. Int J Immunopathol Pharmacol 2010;23:355-8.  Back to cited text no. 81
82.Severo CB, Guazzelli LS, Severo LC. Zigomicose. J Bras Pneumol 2010;36:134-41.   Back to cited text no. 82
83.Liu M, Spellberg B, Phan QT, Fu Y, Fu Y, Lee AS, et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest 2010;120:1914-24.  Back to cited text no. 83
84.Alves C, Andion J, Brandão M, Menezes R. Pathogenic aspects of the periodontal disease associated to diabetes mellitus. Arq Bras Endocrinol Metab 2007;51:1050-7.  Back to cited text no. 84
85.Nagasawa T, Noda M, Katagiri S, Takaichi M, Takahashi Y, Wara-Aswapati N, et al. Relationship between periodontitis and diabetes - importance of a clinical study to prove the vicious cycle. Intern Med 2010;49:881-5.  Back to cited text no. 85
86.Simpson TC, Needleman I, Wild SH, Moles DR, Mills EJ. Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev 2010;5:CD004714.  Back to cited text no. 86
87.Kalra S, Kalra B, Agrawal N, Unnikrishnan AG. Understanding diabetes in patients with HIV/AIDS. Diabetol Metab Syndr 2011;3:2.  Back to cited text no. 87
88.Alves C, Oliveira AC, Brites C. Lipodystrophic syndrome in children and adolescents infected with the human immunodeficiency virus. Braz J Infect Dis 2008;12:342-8.  Back to cited text no. 88
89.Takarabe D, Rokukawa Y, Takahashi Y, Goto A, Talkaichi M, Okamoto M, et al. Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy. J Clin Endocrinol Metab 2010;95:4056-60.  Back to cited text no. 89
90.Van der Werf N, Kroese FG, Rozing J, Hillebrands JL. Viral infections as potential trigger of type 1 diabetes. Diabetes Metab Res Rev 2007;23:169-83.  Back to cited text no. 90


  [Figure 1]

  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 GC-MS Chemical Constituents and in vitro Activities of the Oil Extract of Euryops brevipapposus Leaves used Traditionally for the Management of Some Diseases
Abiodun Atinuke Adegborioye,Oyinlola Oluwunmi Olaokun,Benson Chuks Iweriebor,Larry Chikwulu Obi
Asian Journal of Chemistry. 2021; 33(3): 677
[Pubmed] | [DOI]
2 Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
Mutasem Elfalah,Saif Aldeen AlRyalat,Mario Damiano Toro,Robert Rejdak,Sandrine Zweifel,Rashed Nazzal,Mohammed Abu-Ameerh,Osama Ababneh,Almutez Gharaibeh,Zuhair Sharif,Jehad Meqbil,Moćath AlShawabkeh,Amal Alwreikat,Muawyah Al Bdour,Maysa Al-Hussaini,Yacoub A Yousef
Clinical Ophthalmology. 2021; Volume 15: 661
[Pubmed] | [DOI]
3 Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives
Aman Rajpal,Laure Sayyed Kassem,David C Aron
Expert Review of Endocrinology & Metabolism. 2021;
[Pubmed] | [DOI]
4 Pyogenic Liver Abscess Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide, Population-Based Cohort Study
Tzu-Yuan Wang,Hsueh-Chou Lai,Hsin-Hung Chen,Mei-Lin Wang,Ming-Chia Hsieh,Chwen-Tzuei Chang,Rong-Hsing Chen,Chun-Wei Ho,Yi-Chin Hung,Juei-Yu Tseng,Cheng-Li Lin,Chia-Hung Kao
Frontiers in Medicine. 2021; 8
[Pubmed] | [DOI]
5 Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia
Akhmad Priyadi,Hikmat Permana,Ahmad Muhtadi,Sri A. Sumiwi,Rano K. Sinuraya,Auliya A. Suwantika
Healthcare. 2021; 9(2): 211
[Pubmed] | [DOI]
6 Chronic Running Exercise Regulates Cytotoxic Cell Functions and Zinc Transporter SLC39A10/ZIP10 Levels in Diabetic Rats
Ibrahim Ugurlu,Saltuk Bugra Baltaci,Omer Unal,Rasim Mogulkoc,Hulya Ucaryilmaz,Abdulkerim Kasim Baltaci
Biological Trace Element Research. 2021;
[Pubmed] | [DOI]
7 Clinical and Radiological Presentations of Various Pulmonary Infections in Hospitalized Diabetes Mellitus Patients: A Prospective, Hospital-Based, Comparative, Case Series Study
Pravesh Vishwakarma,Kauser Usman,Rajiv Garg,Jyoti Bajpai,Rishi Sethi,Akshyaya Pradhan,Yongchun Shen
Pulmonary Medicine. 2021; 2021: 1
[Pubmed] | [DOI]
8 Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis
Harun Gür,Onur Ismi,Yusuf Vayisoglu,Kemal Görür,Rabia Bozdogan Arpaci,Elif Sahin Horasan,Cengiz Özcan
European Archives of Oto-Rhino-Laryngology. 2021;
[Pubmed] | [DOI]
9 Association of Comorbid Diabetes With Clinical Outcomes and Healthcare Utilization in Colorectal Cancer Survivors
Susan Storey,Zuoyi Zhang,Xiao Luo,Diane Von Ah,Megan Metzger,Jie Zhang,Amrutha Jakka,Kun Huang
Oncology Nursing Forum. 2021; 48(2): 195
[Pubmed] | [DOI]
10 Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus
Miriam Bobadilla-del-Valle,Francisco Leal-Vega,Pedro Torres-Gonzalez,Anabel Ordaz-Vazquez,Maria de Lourdes Garcia-Garcia,Ma. de los Angeles Tovar-Vargas,Guadalupe Delgado-Sanchez,Paola Del Carmen Guerra De Blas,Robert S. Wallis,Alfredo Ponce-De-León,José Sifuentes-Osornio
Frontiers in Cellular and Infection Microbiology. 2021; 11
[Pubmed] | [DOI]
11 Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach
Shilpi Kashyap,Rajni Bala,Reecha Madaan,Tapan Behl
Environmental Science and Pollution Research. 2021;
[Pubmed] | [DOI]
12 Corpus spongiosum abscess presented as new-onset diabetes in an adult patient: a case presentation
Anatolian Current Medical Journal. 2021; 3(1): 69
[Pubmed] | [DOI]
13 Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia
Jesús Chávez-Reyes,Carlos E. Escárcega-González,Erika Chavira-Suárez,Angel León-Buitimea,Priscila Vázquez-León,José R. Morones-Ramírez,Carlos M. Villalón,Andrés Quintanar-Stephano,Bruno A. Marichal-Cancino
Frontiers in Public Health. 2021; 9
[Pubmed] | [DOI]
14 The Interplay Between Sugar and Yeast Infections: Do Diabetics Have a Greater Predisposition to Develop Oral and Vulvovaginal Candidiasis?
Lubna Mohammed,Gaurav Jha,Iana Malasevskaia,Harshit K Goud,Aiman Hassan
Cureus. 2021;
[Pubmed] | [DOI]
15 Estimating The Efficiency Of Phagocytic Neutrophil Cells And Studying Its Risk Factors Among Diabetic Foot Ulcers
M H Baras,E A Bin-Hameed
Journal of Physics: Conference Series. 2021; 1900(1): 012006
[Pubmed] | [DOI]
16 COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Cyril P. Landstra,Eelco J. P. de Koning
Frontiers in Endocrinology. 2021; 12
[Pubmed] | [DOI]
17 Thoracic Osteomyelitis and Eustachian Valve Endocarditis: A Case Report and Literature Review
Sheila D Hernandez,Maxwell J Jabaay,Dario A Marotta,Sebastian T Tosto,Arash Velayati
Cureus. 2021;
[Pubmed] | [DOI]
18 Analysis of CD4 and CD8 expression in multidrug-resistant tuberculosis infection with diabetes mellitus: An experimental study in mice
Heidy Agustin,Muhammad Nasrum Massi,Irawati Djaharuddin,Agus Dwi Susanto,Andi Asadul Islam,Mochammad Hatta,Agussalim Bukhari,Nur Ahmad Tabri,Arif Santoso,Ilhamjaya Patellongi
Annals of Medicine and Surgery. 2021; : 102596
[Pubmed] | [DOI]
19 Bioactive Carboxymethyl Starch-Based Hydrogels Decorated with CuO Nanoparticles: Antioxidant and Antimicrobial Properties and Accelerated Wound Healing In Vivo
Zahra Abdollahi,Ehsan Nazarzadeh Zare,Fatemeh Salimi,Iran Goudarzi,Franklin R. Tay,Pooyan Makvandi
International Journal of Molecular Sciences. 2021; 22(5): 2531
[Pubmed] | [DOI]
20 Acute Appendicitis in a Diabetic Child with Salmonella Infection
Stylianos Roupakias,Maria-Ioanna Apostolou,Anastasia Anastasiou
Prague Medical Report. 2021; 122(1): 34
[Pubmed] | [DOI]
21 Characteristics of Asymptomatic Bacteriuria in Diabetes Mellitus Patients: A Retrospective Observational Study
Muhammad Sohaib Asghar,Mohammed Akram,Manjeet Singh,Farah Yasmin,Rabail Yaseen,Nisar Ahmed,Mariam Siddiqui,Maira Hassan,Uzma Rasheed,Abraish Ali
Cureus. 2021;
[Pubmed] | [DOI]
22 Potential Pathogenicity of Candida Species Isolated from Oral Cavity of Patients with Diabetes Mellitus
Hasti Nouraei,Mehdi Ghaderian Jahromi,Leila Razeghian Jahromi,Kamiar Zomorodian,Keyvan Pakshir,Himanshu Garg
BioMed Research International. 2021; 2021: 1
[Pubmed] | [DOI]
23 Cellular metabolism in the defense against microbes
Lena Pernas
Journal of Cell Science. 2021; 134(5): jcs252023
[Pubmed] | [DOI]
24 Case Report: Diabetic urinary auto-brewery and review of literature
Abdulrahman A. Alduraywish
F1000Research. 2021; 10: 407
[Pubmed] | [DOI]
25 Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential
Yanyan Que,Man Cao,Jianquan He,Qiang Zhang,Qiongyun Chen,Changsheng Yan,Aiqiang Lin,Luxi Yang,Zezhen Wu,Dan Zhu,Fengwu Chen,Zhangran Chen,Chuanxing Xiao,Kaijian Hou,Bangzhou Zhang
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
26 Diabetes und Impfen
Sarah Lignitz,Fred Zepp
Diabetologie und Stoffwechsel. 2021; 16(03): 199
[Pubmed] | [DOI]
27 Clinical outcomes in patients with native valve infective endocarditis and diabetes mellitus
Temidayo Abe,Harry Onoriode Eyituoyo,Gabrielle De Allie,Titilope Olanipekun,Valery Sammah Effoe,Kikelomo Olaosebikan,Paul Mather
World Journal of Cardiology. 2021; 13(1): 11
[Pubmed] | [DOI]
28 Increased insulin and GLUT2 gene expression and elevated glucokinase activity in ß-like cells of islets of langerhans differentiated from human haematopoietic stem cells on treatment with Costus igneus leaf extract
Surekha Kattaru,Sunitha Manne Mudhu,Samundeshwari Echambadi Loganathan,Sireesha Kodavala,Venkata Gurunadha Krishna Sarma Potukuchi
Molecular Biology Reports. 2021;
[Pubmed] | [DOI]
29 Comparative profile for COVID-19 cases from China and North America: Clinical symptoms, comorbidities and disease biomarkers
Alaa Badawi,Denitsa Vasileva
World Journal of Clinical Cases. 2021; 9(1): 118
[Pubmed] | [DOI]
30 Low Vibrational Training as an Additional Intervention for Postural Balance, Balance Confidence and Functional Mobility in Type 2 Diabetic Patients with Lower Limb Burn Injury: A Randomized Clinical Trial
Zizi M Ibrahim,Olfat Ibrahim Ali,Samah A Moawd,Marwa M Eid,Mona Mohamed Taha
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021; Volume 14: 3617
[Pubmed] | [DOI]
31 High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Jie Zhu,Wenjuan Yang,Xiangda Zhou,Dorina Zöphel,Leticia Soriano-Baguet,Denise Dolgener,Christopher Carlein,Chantal Hof,Renping Zhao,Shandong Ye,Eva C. Schwarz,Dirk Brenner,Leticia Prates Roma,Bin Qu
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
32 Altered VDAC-HK association and apoptosis in mouse peripheral blood lymphocytes exposed to diabetic condition: an in vitro and in vivo study
Melinda Nongbet Sohlang,Suktilang Majaw
Archives of Physiology and Biochemistry. 2021; : 1
[Pubmed] | [DOI]
33 Blood glucose promotes dengue virus infection in the mosquito Aedes aegypti
Shih-Che Weng,Po-Nien Tsao,Shin-Hong Shiao
Parasites & Vectors. 2021; 14(1)
[Pubmed] | [DOI]
34 Immunomodulatory Properties of Host Defence Peptides in Skin Wound Healing
Marija Petkovic,Michelle Vang Mouritzen,Biljana Mojsoska,Hĺvard Jenssen
Biomolecules. 2021; 11(7): 952
[Pubmed] | [DOI]
35 Oral Health Messiers: Diabetes Mellitus Relevance
Rahnuma Ahmad,Mainul Haque
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021; Volume 14: 3001
[Pubmed] | [DOI]
36 Corpora Amylacea in the Human Brain Exhibit Neoepitopes of a Carbohydrate Nature
Marta Riba,Elisabet Augé,Iraida Tena,Jaume del Valle,Laura Molina-Porcel,Teresa Ximelis,Jordi Vilaplana,Carme Pelegrí
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
37 Type 1 Diabetes Patients’ Practice, Knowledge and Attitudes towards Influenza Immunization
Giulia Dallagiacoma,Agnese Allora,Stefano Salvati,Giulia Cocciolo,Michele Capraro,Anna Lamberti,Sabrina Senatore,Leandro Gentile,Vincenza Gianfredi,Andrea Laurenzi,Chiara Molinari,Amelia Caretto,Marino Faccini,Carlo Signorelli,Marina Scavini,Anna Odone
Vaccines. 2021; 9(7): 707
[Pubmed] | [DOI]
38 Phytochemicals and Their Possible Mechanisms in Managing COVID-19 and Diabetes
Eli Mireya Sandoval-Gallegos,Esther Ramírez-Moreno,Nancy Vargas-Mendoza,José Arias-Rico,Diego Estrada-Luna,José Javier Cuevas-Cancino,Reyna Cristina Jiménez-Sánchez,Olga Rocío Flores-Chávez,Rosa María Baltazar-Téllez,José A. Morales-González
Applied Sciences. 2021; 11(17): 8163
[Pubmed] | [DOI]
39 Impact of kidney size on mortality in diabetic patients receiving peritoneal dialysis
Chun-Hao Chen,Chao-Yu Chen,Mei-Ching Yu,Jen-Fen Fu,Yi-Chou Hou,I.-Kuan Wang,Yu-Hsin Chih,Cheng-Hao Weng,Wen-Hung Huang,Ching-Wei Hsu,Frederick W. K. Tam,Tzung-Hai Yen
Scientific Reports. 2021; 11(1)
[Pubmed] | [DOI]
40 Prevalence of Diagnosed Diabetes Among Employed US Adults by Demographic Characteristics and Occupation, 36 States, 2014 to 2018
Taylor M. Shockey,Rebecca J. Tsai,Pyone Cho
Journal of Occupational & Environmental Medicine. 2021; 63(4): 302
[Pubmed] | [DOI]
41 How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group
Francesca Ferretti,Rosanna Cannatelli,Maurizio Benucci,Stefania Carmagnola,Emilio Clementi,Piergiorgio Danelli,Dario Dilillo,Paolo Fiorina,Massimo Galli,Maurizio Gallieni,Giovanni Genovese,Valeria Giorgi,Alessandro Invernizzi,Giovanni Maconi,Jeanette A. Maier,Angelo V. Marzano,Paola S. Morpurgo,Manuela Nebuloni,Dejan Radovanovic,Agostino Riva,Giuliano Rizzardini,Gianmarco Sabiu,Pierachille Santus,Giovanni Staurenghi,Gianvincenzo Zuccotti,Pier Carlo Sarzi-Puttini,Sandro Ardizzone
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
42 United States immigration detention amplifies disease interaction risk: A model for a transnational ICE-TB-DM2 syndemic
Ashley R. Houston,Kathleen Lynch,Bayla Ostrach,Yoshua Seidner Isaacs,Carolina Nvé Díaz San Francisco,Jae Moo Lee,Nicholas Emard,Dylan Atchley Proctor
Global Public Health. 2021; : 1
[Pubmed] | [DOI]
43 Impact of comorbidities on mortality in hospitalized influenza patients with diabetes – Analysis of the Austrian Health Insurance
Faisal Aziz,Felix Aberer,Othmar Moser,Caren Sourij,Dirk von Lewinski,Susanne Kaser,Berthold Reichardt,Harald Sourij
Diabetes Research and Clinical Practice. 2021; 174: 108758
[Pubmed] | [DOI]
44 Cause-specific mortality in children and young adults with diabetes mellitus: A Danish nationwide cohort study
Jesper Svane,Thomas H Lynge,Ulrik Pedersen-Bjergaard,Thomas Jespersen,Gunnar H Gislason,Bjarke Risgaard,Bo G Winkel,Jacob Tfelt-Hansen
European Journal of Preventive Cardiology. 2021; 28(2): 159
[Pubmed] | [DOI]
45 In-Hospital Outcomes of Inflammatory Bowel Diseases in Patients With Diabetes Mellitus: A Propensity Score Matching Analysis
Ese Uwagbale,Omolara G Adeniran,Olayemi A Adeniran,Ifeanyichukwu Onukogu,Solomon Agbroko,Niket Sonpal
Cureus. 2021;
[Pubmed] | [DOI]
46 Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery
Anna Rzucidlo-Hymczak,Hubert Hymczak,Anna Kedziora,Boguslaw Kapelak,Rafal Drwila,Dariusz Plicner,Robert Jeenchen Chen
PLOS ONE. 2021; 16(3): e0248512
[Pubmed] | [DOI]
47 Nasal Methicillin-Resistant Staphylococcus aureus Colonization in Patients with Type 1 Diabetes in Taiwan
Chun-Ya Kang,Eugene Yu-Chuan Kang,Chi-Chun Lai,Wei-Che Lo,Kun-Jen Chen,Wei-Chi Wu,Laura Liu,Yih-Shiou Hwang,Fu-Sung Lo,Yhu-Chering Huang
Microorganisms. 2021; 9(6): 1296
[Pubmed] | [DOI]
48 Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities
Alba Llibre,Martin Dedicoat,Julie G. Burel,Caroline Demangel,Matthew K. O’Shea,Claudio Mauro
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
49 Bio-fabrication of titanium oxide nanoparticles from Ochradenus arabicus to obliterate biofilms of drug-resistant Staphylococcus aureus and Pseudomonas aeruginosa isolated from diabetic foot infections
Mohammad Zubair,Fohad Mabood Husain,Faizan Abul Qais,Pravej Alam,Iqbal Ahmad,Thamer Albalawi,Naushad Ahmad,Manawwer Alam,Mohammad Hassan Baig,Jae-June Dong,Farha Fatima,Badr Alsayed
Applied Nanoscience. 2021;
[Pubmed] | [DOI]
50 Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations
Massimo Andreoni,Laura Sticchi,Silvia Nozza,Loredana Sarmati,Andrea Gori,Marcello Tavio
Human Vaccines & Immunotherapeutics. 2021; : 1
[Pubmed] | [DOI]
51 Assessment of suspected adverse drug reactions in elderly patients with diabetes mellitus based on a Portuguese spontaneous reporting database: analysis of reporting from 2008 to 2018
Cristina Monteiro,Samuel Silvestre,Ana Paula Duarte,Gilberto Alves
Expert Opinion on Drug Safety. 2021;
[Pubmed] | [DOI]
52 COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
M. Puig-Domingo,M. Marazuela,B. O. Yildiz,A. Giustina
Endocrine. 2021;
[Pubmed] | [DOI]
53 The perils of perioperative dysglycemia
Micah T. Long,Douglas B. Coursin
International Anesthesiology Clinics. 2020; 58(1): 21
[Pubmed] | [DOI]
54 Will My Fracture Surgery Get Infected? Evidence-based Risk Factors
Brent Wise,Renan Castillo,Manjari Joshi,Robert V. O’Toole
Techniques in Orthopaedics. 2020; 35(2): 100
[Pubmed] | [DOI]
55 Finegoldia magna, an Anaerobic Gram-Positive Bacterium of the Normal Human Microbiota, Induces Inflammation by Activating Neutrophils
Ariane Neumann,Lars Björck,Inga-Maria Frick
Frontiers in Microbiology. 2020; 11
[Pubmed] | [DOI]
56 Agar–Iodine Transdermal Patches for Infected Diabetic Wounds
Suhela Tyeb,Nitesh Kumar,Ashok Kumar,Vivek Verma
ACS Applied Bio Materials. 2020;
[Pubmed] | [DOI]
57 Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients
Leonidas Palaiodimos,Natalia Chamorro-Pareja,Dimitrios Karamanis,Weijia Li,Phaedon D. Zavras,Kai Ming Chang,Priyanka Mathias,Damianos G. Kokkinidis
Hormones. 2020;
[Pubmed] | [DOI]
58 COVID-19 and diabetes: The why, the what and the how
Sarah Cuschieri,Stephan Grech
Journal of Diabetes and its Complications. 2020; : 107637
[Pubmed] | [DOI]
59 Psoriasis in patients with metabolic syndrome: clinical aspects of the problem
S.G. Lykova,M.A. Morzhanaeva,O.B. Nemchaninova,E.V. Svechnikova
Klinicheskaya dermatologiya i venerologiya. 2020; 19(2): 214
[Pubmed] | [DOI]
60 Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic
M. Cuypers,B. W. M. Schalk,M. C. J. Koks-Leensen,M. E. Nägele,E. J. Bakker-van Gijssel,J. Naaldenberg,G. L. Leusink
Journal of Intellectual Disability Research. 2020;
[Pubmed] | [DOI]
61 Boron doped silver-copper alloy nanoparticle targeting intracellular S. aureus in bone cells
Tahir Abdulrehman,Shahnaz Qadri,Sini Skariah,Ali Sultan,Said Mansour,Jamil Azzi,Yousef Haik,Amitava Mukherjee
PLOS ONE. 2020; 15(4): e0231276
[Pubmed] | [DOI]
62 Type 2 diabetes mellitus – IL-8 and IL-10 profile in patients with intraabdominal postoperative abscesses
Valeriy V. Boyko,Artem S. Riga
Wiadomosci Lekarskie. 2020; 73(2): 220
[Pubmed] | [DOI]
63 Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019
Robert J Wilkinson
Clinical Infectious Diseases. 2020;
[Pubmed] | [DOI]
64 Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies
Muhammad Sajid Hamid Akash,Kanwal Rehman,Fareeha Fiayyaz,Shakila Sabir,Mohsin Khurshid
Archives of Microbiology. 2020;
[Pubmed] | [DOI]
65 COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology
M. Puig-Domingo,M. Marazuela,A. Giustina
Endocrine. 2020; 68(1): 2
[Pubmed] | [DOI]
66 Risk for developing perianal abscess in type 1 and type 2 diabetes and the impact of poor glycemic control
Karin Adamo,Ulf Gunnarsson,Katarina Eeg-Olofsson,Karin Strigĺrd,Fredrik Brännström
International Journal of Colorectal Disease. 2020;
[Pubmed] | [DOI]
67 Aeromedical retrieval diagnostic trends during a period of Coronavirus 2019 lockdown
Fergus W. Gardiner,Marianne Gillam,Leonid Churilov,Pritish Sharma,Mardi Steere,Michelle Hannan,Andrew Hooper,Frank Quinlan
Internal Medicine Journal. 2020; 50(12): 1457
[Pubmed] | [DOI]
68 COVID-19 and diabetes: What does the clinician need to know?
Eleni Papadokostaki,Nikolaos Tentolouris,Evangelos Liberopoulos
Primary Care Diabetes. 2020;
[Pubmed] | [DOI]
69 Trichosporon Species and Fusarium Species as a Cause of Empyema Thoracis in a Diabetic Patient
Nousheen Iqbal,Muhammad Ammar,Muhammad Irfan,Kauser Jabeen
Cureus. 2020;
[Pubmed] | [DOI]
70 Endocrine and metabolic aspects of the COVID-19 pandemic
Mónica Marazuela,Andrea Giustina,Manuel Puig-Domingo
Reviews in Endocrine and Metabolic Disorders. 2020;
[Pubmed] | [DOI]

Blood Neutrophil-to-Lymphocyte Ratio and Urine IL-8 Levels Predict the Type of Bacterial Urinary Tract Infection in Type 2 Diabetes Mellitus Patients

Fatemeh Saheb Sharif-Askari,Narjes Saheb Sharif-Askari,Adnane Guella,Ali Alabdullah,Hour Bashar Al Sheleh,Afnan Maher Hoory AlRawi,Enad Sami Haddad,Qutayba Hamid,Rabih Halwani,Rifat Hamoudi
Infection and Drug Resistance. 2020; Volume 13: 1961
[Pubmed] | [DOI]
72 Micosis pulmonares en pacientes con diabetes mellitus. Características clínicas y factores de riesgo
Alejandro Hernández-Solísa,Alejandra Camerino Guerrero,Yesenia Colín Muńoz,Saret Bazán Cuervo,Raúl Cícero Sabido,Arturo Reding-Bernal
Revista Iberoamericana de Micología. 2020;
[Pubmed] | [DOI]
73 Recalcitrant Foot Ulceration in a Patient With Type 1 Diabetes Mellitus
Stephan Vazeille,Lydia Hawker,Ramasubramanyan Chandrasekar,Upendram Srinivas-Shankar
Cureus. 2020;
[Pubmed] | [DOI]
74 Gauging the Risk Factors for Asymptomatic Bacteriuria in Type-2 Diabetic Women: A Case-Control Study
Syed Muhammad Jawad Zaidi,Mehwish Kaneez,Talal Almas,Laiba Fatima,Hafiz Abu Safian,Ali Murad Jamal,Muhammad Zubair Satti,Rubaid A Dhillon,Abdullah Bin Zubair,Syed Faheem Bukhari
Cureus. 2020;
[Pubmed] | [DOI]
75 Seropositivity for pathogens associated with chronic infections is a risk factor for all-cause mortality in the elderly: findings from the Memory and Morbidity in Augsburg Elderly (MEMO) Study
Marius Zeeb,Tobias Kerrinnes,Luka Cicin-Sain,Carlos A. Guzman,Wolfram Puppe,Thomas F. Schulz,Annette Peters,Klaus Berger,Stefanie Castell,André Karch
GeroScience. 2020;
[Pubmed] | [DOI]
76 The Impact of COVID-19 Pandemic on Diabetic Children: A Systematic Review on the Current Evidence
Shafi U Bhuiyan,Hanaa M Badran
International journal of community medicine and Health Education. 2020; : 1
[Pubmed] | [DOI]
77 The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Gholamreza Daryabor,Mohamad Reza Atashzar,Dieter Kabelitz,Seppo Meri,Kurosh Kalantar
Frontiers in Immunology. 2020; 11
[Pubmed] | [DOI]
78 Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review
Subham Das,Anu K.R.,Sumit Raosaheb Birangal,Ajinkya Nitin Nikam,Abhijeet Pandey,Srinivas Mutalik,Alex Joseph
Life Sciences. 2020; 258: 118202
[Pubmed] | [DOI]
79 Jabuticaba ( Plinia trunciflora (O. Berg) Kausel) improved the lipid profile and immune system and reduced oxidative stress in streptozotocin-induced diabetic rats
Caroline Calloni,Luana Soares Martínez,Daniela Franciele Gil,Douglas Machado Silva,Pauline Fagundes Rosales,Fabiana Agostini,Sidnei Moura e Silva,Matheus Parmegiani Jahn,Mirian Salvador
Journal of Food Biochemistry. 2020;
[Pubmed] | [DOI]
80 Uncommon Association Between Diabetic Ketoacidosis, Thyrotoxicosis, Cutaneous Abscess and Acute Pericarditis in an Immunocompetent Patient: A Single Case Report and Literature Review
Martinot Amelie,Demar Magalie,Thelusme Liliane,Bounoua Merzaka,Santa Florin,Dueymes Maryvonne,Vujica Jelena,Dequidt Henry,Sabbah Nadia
Current Diabetes Reviews. 2020; 16(6): 641
[Pubmed] | [DOI]
81 Glucose induces metabolic reprogramming in neutrophils during type 2 diabetes to form constitutive extracellular traps and decreased responsiveness to lipopolysaccharides
Manjunath B. Joshi,Rayees Ahamed,Mangala Hegde,Aswathy S. Nair,Lingadakai Ramachandra,Kapaettu Satyamoorthy
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2020; : 165940
[Pubmed] | [DOI]
82 The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review
Andrew Y. Chang,Mark R. Cullen,Robert A. Harrington,Michele Barry
Journal of Internal Medicine. 2020;
[Pubmed] | [DOI]
83 Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections
Brianna J. Stubbs,Andrew P. Koutnik,Emily L. Goldberg,Vaibhav Upadhyay,Peter J. Turnbaugh,Eric Verdin,John C. Newman
Med. 2020;
[Pubmed] | [DOI]
84 COVID-19 and type 1 diabetes: dealing with the difficult duo
Subhankar Chowdhury,Soumik Goswami
International Journal of Diabetes in Developing Countries. 2020;
[Pubmed] | [DOI]
85 Obesity population at risk of COVID-19 complications
Sarah Cuschieri,Stephan Grech
Global Health, Epidemiology and Genomics. 2020; 5
[Pubmed] | [DOI]
86 Diabetic Ketoacidosis: Clinical Characteristics and Precipitating Factors
Wajeeha Shahid,Faria Khan,Aamir Makda,Vinesh Kumar,Sidra Memon,Amber Rizwan
Cureus. 2020;
[Pubmed] | [DOI]
87 Clinician Assessment Tools for Patients with Diabetic Foot Disease: A Systematic Review
Raúl Fernández-Torres,María Ruiz-Muńoz,Alberto J. Pérez-Panero,Jerónimo C. García-Romero,Manuel Gónzalez-Sánchez
Journal of Clinical Medicine. 2020; 9(5): 1487
[Pubmed] | [DOI]
88 Impact of Diabetes Mellitus on Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
Hsuan-Chih Kuo,Pei-Hung Chang,Cheng-Hsu Wang
Scientific Reports. 2020; 10(1)
[Pubmed] | [DOI]
89 Risk factor for Mycobacterium leprae detection in household contact with leprosy patient: a study in Papua, East Indonesia
Hana Krismawati,Antonius Oktavian,Yustinus Maladan,Tri Wahyuni
Medical Journal of Indonesia. 2020; 29(1): 64
[Pubmed] | [DOI]
90 Growth of Diabetes Research in United Arab Emirates: Current and Future Perspectives
Mohamad Shieb,Sema Koruturk,Ankita Srivastava,Bashair M. Mussa
Current Diabetes Reviews. 2020; 16(4): 395
[Pubmed] | [DOI]
91 Vaccines recommended for diabetic patients
Petra Macounová,Rastislav Madar
Vnitrní lékarství. 2020; 66(5): 301
[Pubmed] | [DOI]
92 Ozone sterilization: Renewed potential for combating bacterial infections in severe burns, decubitus, and leg ulcers
Yasuhiro Horiuchi
Infection Control & Hospital Epidemiology. 2020; : 1
[Pubmed] | [DOI]
93 Smoking is associated with a higher risk of unplanned medical visits among adult patients with diabetes, using retrospective electronic medical record data from 2014 to 2016
Arielle Selya,Eric L. Johnson,Tess L. Weber,Jaymi Russo,Cheryl Stansbury,Drake Anshutz,Emily Griese,Benson Hsu
BMC Health Services Research. 2020; 20(1)
[Pubmed] | [DOI]
94 Managing diabetes during the COVID-19 pandemic
David Morris
Practice Nursing. 2020; 31(11): 450
[Pubmed] | [DOI]
95 Infections in children with diabetes
Luis Eduardo Calliari,Flávia J. Almeida,Renata Maria Noronha
Jornal de Pediatria (Versăo em Portuguęs). 2020; 96: 39
[Pubmed] | [DOI]
96 Whey Proteins and Its Derivatives: Bioactivity, Functionality, and Current Applications
Shayanti Minj,Sanjeev Anand
Dairy. 2020; 1(3): 233
[Pubmed] | [DOI]
97 Necrotizing Soft Tissue Infections in the Vasculopathic Patient: Review of Literature
Chi Lap Nicholas Tsang,Jerry Cao,Prashanth Gunanayagam,Rui Feitosa,Andrew Bullen
International Surgery. 2020; 104(1-2): 75
[Pubmed] | [DOI]
98 Prevalence and Subtype Distribution of Blastocystis Infection in Patients with Diabetes Mellitus in Thailand
Noppon Popruk,Satakamol Prasongwattana,Aongart Mahittikorn,Attakorn Palasuwan,Supaluk Popruk,Duangdao Palasuwan
International Journal of Environmental Research and Public Health. 2020; 17(23): 8877
[Pubmed] | [DOI]
99 Preconditioning of Human Decidua Basalis Mesenchymal Stem/Stromal Cells with Glucose Increased Their Engraftment and Anti-diabetic Properties
Yasser Basmaeil,Manar Al Rashid,Tanvir Khatlani,Manal AlShabibi,Eman Bahattab,Meshan L. Abdullah,Fawaz Abumary,Bill Kalionis,Safia Massoudi,Mohammad AbuMaree
Tissue Engineering and Regenerative Medicine. 2020;
[Pubmed] | [DOI]
100 Chrysophyllum cainito: A Tropical Fruit with Multiple Health Benefits
Hau V. Doan,Thao P. Le
Evidence-Based Complementary and Alternative Medicine. 2020; 2020: 1
[Pubmed] | [DOI]
101 Characteristics and Outcomes of Children with Type-I Diabetes Mellitus Hospitalized for Ketoacidosis
Roza Zinab Ababulgu,Behailu Terefe Tesfaye
Current Diabetes Reviews. 2020; 16(7): 779
[Pubmed] | [DOI]
102 Bacteriological profile and antibiotic susceptibility of diabetic Foot infections at Ribat University hospital; a retrospective study from Sudan
Maram H. Hamid,Ahmed H. Arbab,Bashir A. Yousef
Journal of Diabetes & Metabolic Disorders. 2020;
[Pubmed] | [DOI]
103 Towards Detecting Infection Incidences in People with Type 1 Diabetes Using Self-Recorded Data: A Novel Framework for a Digital Infectious Disease Detection System (Preprint)
Ashenafi Zebene Woldaregay,Ilkka Kalervo Launonen,Eirik Ĺrsand,David Albers,Anna Holubová,Gunnar Hartvigsen
Journal of Medical Internet Research. 2020;
[Pubmed] | [DOI]
104 Predictive value of common serum glycaemic markers on periprosthetic joint infection following Total Joint Arthroplasty: A review of the literature
Yogen Thever,Bryon Jun Xiong Teo,Hwee Chye Andrew Tan
Journal of Orthopaedics. 2020; 22: 278
[Pubmed] | [DOI]
105 Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
Malgorzata Kloc,Rafik M. Ghobrial,Slawomir Lewicki,Jacek Z. Kubiak
Journal of Diabetes & Metabolic Disorders. 2020;
[Pubmed] | [DOI]
106 COVID-19 Endocrinopathy with Hindsight from SARS
Narasimhan Kothandaraman,Rengaraj Anantharaj,Bo Xue,Wen Shan Yew,S. Sendhil Velan,Neerja Karnani,Melvin Khee-Shing Leow
American Journal of Physiology-Endocrinology and Metabolism. 2020;
[Pubmed] | [DOI]
107 Neurological Associations of COVID-19—Do We Know Enough: A Tertiary Care Hospital Based Study
Suman Kushwaha,Vaibhav Seth,Prateek Bapat,KiranGowda R,Monali Chaturvedi,Renu Gupta,Sonali Bhattar,Siddharth Maheshwari,Aldrin Anthony
Frontiers in Neurology. 2020; 11
[Pubmed] | [DOI]
108 Unbalanced production of LTB4/PGE2 driven by diabetes increases susceptibility to cutaneous leishmaniasis
Icaro Bonyek-Silva,Sara Nunes,Reinan L. Santos,Filipe R. Lima,Alexsandro Lago,Juliana Silva,Lucas P. Carvalho,Sergio M. Arruda,Henrique C. Serezani,Edgar M. Carvalho,Claudia I. Brodskyn,Natalia M. Tavares
Emerging Microbes & Infections. 2020; 9(1): 1275
[Pubmed] | [DOI]
109 A Review of the Risk Factors Associated With Poor Outcomes in Patients With Coronavirus Disease 2019
Muhammad Hanif,Muhammad Adnan Haider,Qianlan Xi,Mukarram Jamat Ali,Muhammad Umer Ahmed
Cureus. 2020;
[Pubmed] | [DOI]
110 Bacterial strains colonizing the sensor electrodes of a continuous glucose monitoring system in children with diabetes
Sebastian Seget,Ewa Rusak,Miroslaw Partyka,Ewa Samulska,Aleksandra Pyziak-Skupien,Halla Kaminska,Eliza Skala-Zamorowska,Przemyslawa Jarosz-Chobot
Acta Diabetologica. 2020;
[Pubmed] | [DOI]

Epidemiological Situation of Necrotizing Fasciitis and Factors in Thailand and Factors Associated with Its Morbidity and Mortality, 2014–2018

Panupong Tantirat,Thanit Rattanathumsakul,Hirunwut Praekunatham,Kumaree Pachanee,Repeepong Suphanchaimat
Risk Management and Healthcare Policy. 2020; Volume 13: 1613
[Pubmed] | [DOI]
112 Challenges in Antifungal Therapy in Diabetes Mellitus
Sazlyna Mohd Sazlly Lim,Mahipal Sinnollareddy,Fekade Bruck Sime
Journal of Clinical Medicine. 2020; 9(9): 2878
[Pubmed] | [DOI]
113 Shaping of Dendritic Cell Function by the Metabolic Micro-Environment
Eline Constance Brombacher,Bart Everts
Frontiers in Endocrinology. 2020; 11
[Pubmed] | [DOI]
114 Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
Casey Means
Metabolism. 2020; 108: 154254
[Pubmed] | [DOI]
115 The relationship between neutrophil-lymphocyte ratio and antibiotic therapy in patients with fever of unknown origin
Sakarya Medical Journal. 2020;
[Pubmed] | [DOI]
116 Chronic wounds and novel therapeutic approaches
Maria Azevedo,Carmen Lisboa,Acácio Rodrigues
British Journal of Community Nursing. 2020; 25(Sup12): S26
[Pubmed] | [DOI]
117 Infections in the diabetic child
Luis Eduardo Calliari,Flávia J. Almeida,Renata Maria Noronha
Jornal de Pediatria. 2019;
[Pubmed] | [DOI]
118 Forecasting the impact of diabetes mellitus on tuberculosis disease incidence and mortality in India
Susanne F Awad,Peijue Huangfu,Houssein H Ayoub,Fiona Pearson,Soha R Dargham,Julia A Critchley,Laith J Abu-Raddad
Journal of Global Health. 2019; 9(2)
[Pubmed] | [DOI]
119 A novel impedance sensing approach for precise electromechanical characterization of cells
Karthik Mahesh,Manoj M Varma,Prosenjit Sen
Journal of Micromechanics and Microengineering. 2019; 29(11): 115001
[Pubmed] | [DOI]
120 Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
George Eduardo Gabriel Kluck,Camila Hübner Costabile Wendt,Guinever Eustaquio do Imperio,Maria Fernanda Carvalho Araujo,Tainá Correa Atella,Isabella da Rocha,Kildare Rocha Miranda,Georgia Correa Atella
Scientific Reports. 2019; 9(1)
[Pubmed] | [DOI]
121 In Vitro and In Vivo Antimicrobial Activity of Antibiotic-Conjugated Carriers with Rapid pH-Responsive Release Kinetics
Sunyoung Kang,Gee Ho Park,Seulah Kim,Jungah Kim,Yoonhwa Choi,Yan Huang,Yan Lee,Tae Hyun Choi
Advanced Healthcare Materials. 2019; : 1900247
[Pubmed] | [DOI]
122 Pharmacotherapy of Lower Respiratory Tract Infections in Elderly—Focused on Antibiotics
Yang Liu,Yan Zhang,Wanyu Zhao,Xiaolei Liu,Fengjuan Hu,Birong Dong
Frontiers in Pharmacology. 2019; 10
[Pubmed] | [DOI]
123 The rash in life-threatening metabolic and endocrine disorders
Fatima N. Mirza,Jonathan S. Leventhal
Clinics in Dermatology. 2019;
[Pubmed] | [DOI]
124 Antidiabetic, antioxidant and antimicrobial activity of the aerial part of Tiliacora triandra
E.A. Makinde,C. Ovatlarnporn,A.E. Adekoya,O.F. Nwabor,O.J. Olatunji
South African Journal of Botany. 2019; 125: 337
[Pubmed] | [DOI]
125 Inhibitory effects of selected antibiotics on the activities of a-amylase and a-glucosidase: In-vitro, in-vivo and theoretical studies
Bita Amiri,Najmeh Sadat Hosseini,Fatemeh Taktaz,Komail Amini,Mehdi Rahmani,Mehdi Amiri,Komail Sadrjavadi,Abolfazl Jangholi,Sajjad Esmaeili
European Journal of Pharmaceutical Sciences. 2019; 138: 105040
[Pubmed] | [DOI]
126 Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites
Lars Bossen,Gitte A. Dam,Hendrik Vilstrup,Hugh Watson,Peter Jepsen
JHEP Reports. 2019;
[Pubmed] | [DOI]
127 Hyperglycemia as a Risk Factor for Postoperative Early Wound Infection after Bicondylar Tibial Plateau Fractures: Determining a Predictive Model Based on Four Methods
Andres Rodriguez-Buitrago,Attum Basem,Ebubechi Okwumabua,Nichelle Enata,Adam Evans,Jacquelyn Pennings,Bernes Karacay,Mark John Rice,William Obremskey
Injury. 2019;
[Pubmed] | [DOI]
128 Associations of cutaneous and extracutaneous infections with hidradenitis suppurativa in U.S. children and adults
H.H. Lee,K.R. Patel,V. Singam,S. Rastogi,J.I. Silverberg
British Journal of Dermatology. 2019;
[Pubmed] | [DOI]
129 Comparison of fluconazole and itraconazole for treatment of rhinomaxillary mucormycosis
Omer sefvan Janjua,Sarah Shah,Ammara Afzal,Sana Mehmood Qureshi
Journal of Surgery and Medicine. 2019;
[Pubmed] | [DOI]
130 Diabetes and Phacoemulsification Cataract Surgery: Difficulties, Risks and Potential Complications
Andrzej Grzybowski,Piotr Kanclerz,Valentín Huerva,Francisco J. Ascaso,Raimo Tuuminen
Journal of Clinical Medicine. 2019; 8(5): 716
[Pubmed] | [DOI]
131 Stability preserving non-standard finite difference schemes for diabetes with tuberculosis infectious model
P. Danumjaya,Merina Dhara
Letters in Biomathematics. 2019; : 1
[Pubmed] | [DOI]
132 Bisifusarium Delphinoides, an Emerging Opportunistic Pathogen in a Burn Patient with Diabetes Mellitus
Ji-Hyun Park,Junsang Oh,Ji-Sun Song,Jayoung Kim,Gi-Ho Sung
Mycobiology. 2019; : 1
[Pubmed] | [DOI]
133 Diffuse Lymph-Nodes Microangiopathy as Concurrent Cause of Immunodeficiency in Long-Term Insulin-Dependent Diabetic Patients
Pietro Muretto
Journal of Obesity and Diabetes. 2019; : 25
[Pubmed] | [DOI]
134 Prognostic Significance of “Nonsolid” Microscopic Metastasis in Merkel Cell Carcinoma Sentinel Lymph Nodes
Emily M. Erstine,Michael T. Tetzlaff,Xuefei Jia,Phyu P. Aung,Victor G. Prieto,Pauline Funchain,Brian R. Gastman,Steven D. Billings,Jennifer S. Ko
The American Journal of Surgical Pathology. 2019; 43(7): 907
[Pubmed] | [DOI]
135 Hand Hygiene Practices Among Adults with Diabetes Living in Communities: The 2015 Korea Community Health Survey
Mi Ah Han
International Journal of Environmental Research and Public Health. 2019; 16(7): 1279
[Pubmed] | [DOI]
136 Dual Gene Expression Analysis Identifies Factors Associated with Staphylococcus aureus Virulence in Diabetic Mice
Rudy Jacquet,Annette E. LaBauve,Lavoisier Akoolo,Shivani Patel,Abdulelah A. Alqarzaee,Tania Wong Fok Lung,Kunal Poorey,Timothy P. Stinear,Vinai C. Thomas,Robert J. Meagher,Dane Parker,Victor J. Torres
Infection and Immunity. 2019; 87(5)
[Pubmed] | [DOI]
137 Kardiyak cerrahi sonrasi gelisen saglik bakimi ile iliskili enfeksiyonlarin degerlendirilmesi-tek merkez deneyimi
Zehra Çagla Karakoç
Dicle Tip Dergisi. 2019; : 461
[Pubmed] | [DOI]
138 Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics
Ana Paula Daga,Vanessa Lumi Koga,Joăo Gabriel Material Soncini,Caroline Martins de Matos,Marcia Regina Eches Perugini,Marsileni Pelisson,Renata Katsuko T. Kobayashi,Eliana Carolina Vespero
Frontiers in Cellular and Infection Microbiology. 2019; 9
[Pubmed] | [DOI]
139 Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis
Birhanu Ayelign,Markos Negash,Meaza Genetu,Tadelo Wondmagegn,Tewodros Shibabaw
Journal of Immunology Research. 2019; 2019: 1
[Pubmed] | [DOI]
140 Serum Interleukin-8 in Patients with Different Origin of Intra-Abdominal Infections in Perioperative Period
Artem Riga,Valeriy Boyko,Yuriy Grirorov
Medical Sciences. 2019; 7(9): 94
[Pubmed] | [DOI]
141 Kontrolsüz Diyabetes Mellitus Vakasinda Nadir Görülen Amfizematöz Piyelonefrit ile Sistit Birlikteligi: Vaka Raporu ve Literatür derlemesi
Kahramanmaras Sütçü Imam Üniversitesi Tip Fakültesi Dergisi. 2019;
[Pubmed] | [DOI]
Fernando Henrique Galvăo Tessaro,Thais Soprani Ayala,Leonardo Mendes Bella,Joilson Oliveira Martins
Immunobiology. 2019;
[Pubmed] | [DOI]
143 Validated 60-Second General Foot Screen
R. Gary Sibbald,Khalad Maliyar,Reneeka Persaud-Jaimangal,James A. Elliott,Alisa Brandon,Bharat Kotru,David G. Armstrong
Advances in Skin & Wound Care. 2019; 32(11): 490
[Pubmed] | [DOI]
144 Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies
Martin Rao,Ernest Dodoo,Alimuddin Zumla,Markus Maeurer
Frontiers in Microbiology. 2019; 10
[Pubmed] | [DOI]
145 Analysis of Risk Factors for Infection in Orthopedic Trauma Patients
Gi Ho Moon,Jae-Woo Cho,Beom Soo Kim,Do Hyun Yeo,Jong-Keon Oh
Journal of Trauma and Injury. 2019; 32(1): 40
[Pubmed] | [DOI]
146 Evaluating All Potential Oral Complications of Diabetes Mellitus
Martijn J. L. Verhulst,Bruno G. Loos,Victor E. A. Gerdes,Wijnand J. Teeuw
Frontiers in Endocrinology. 2019; 10
[Pubmed] | [DOI]
147 Influence of preoperative hemoglobin A1c on early outcomes in patients with diabetes mellitus undergoing off-pump coronary artery bypass surgery
Hye Jin Kim,Jae-Kwang Shim,Young-Nam Youn,Jong-Wook Song,Haeyeon Lee,Young-Lan Kwak
The Journal of Thoracic and Cardiovascular Surgery. 2019;
[Pubmed] | [DOI]
148 Stability Preserving Non-Standard Finite Difference Schemes for Diabetes with Tuberculosis Infectious Model
P. Danumjaya,Merina Dhara
Letters in Biomathematics. 2019; 6(2)
[Pubmed] | [DOI]
149 Impact of Diabetes Mellitus on Radiological Presentation of Pulmonary Tuberculosis in Otherwise Non-Immunocompromised Patients: A Systematic Review
Mohammad Ishraq Zafar,Lu-Lu Chen,Ye Xiaofeng,Feng Gao
Current Medical Imaging Formerly Current Medical Imaging Reviews. 2019; 15(6): 543
[Pubmed] | [DOI]
150 Risk factor analysis on the healing time and infection rate of diabetic foot ulcers in a referral wound care clinic
Khaw Kher Kee,Harikrishna K. R. Nair,Ng Pei Yuen
Journal of Wound Care. 2019; 28(Sup1): S4
[Pubmed] | [DOI]
Mitta Nandini,Rama Devi M,Jaya Bhaskar C
Journal of Evidence Based Medicine and Healthcare. 2018; 5(21): 1653
[Pubmed] | [DOI]
152 Positive Bacteriological Analyses in Individuals With Diabetes Mellitus
Cristian Palmiere,Camilla Tettamanti
The American Journal of Forensic Medicine and Pathology. 2018; 39(2): 126
[Pubmed] | [DOI]
153 High Risk of Deep Neck Infection in Patients with Type 1 Diabetes Mellitus: A Nationwide Population-Based Cohort Study
Geng-He Chang,Meng-Chang Ding,Yao-Hsu Yang,Yung-Hsiang Lin,Chia-Yen Liu,Meng-Hung Lin,Ching-Yuan Wu,Cheng-Ming Hsu,Ming-Shao Tsai
Journal of Clinical Medicine. 2018; 7(11): 385
[Pubmed] | [DOI]
154 The Role of Allograft Inflammatory Factor-1 in the Effects of Experimental Diabetes on B Cell Functions in the Heart
Amrita Sarkar,Sanket K. Shukla,Aseel Alqatawni,Anil Kumar,Sankar Addya,Alexander Y. Tsygankov,Khadija Rafiq
Frontiers in Cardiovascular Medicine. 2018; 5
[Pubmed] | [DOI]
155 Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis
Rubens P. Homme,Mahavir Singh,Avisek Majumder,Akash K. George,Kavya Nair,Harpal S. Sandhu,Neetu Tyagi,David Lominadze,Suresh C Tyagi
Frontiers in Physiology. 2018; 9
[Pubmed] | [DOI]
156 Concurrent Use of Sulfonylureas and Antimicrobials of the Elderly in Korea: A Potential Risk of Hypoglycemia
Sera Lee,Miyoung Ock,Hyunah Kim
Korean Journal of Clinical Pharmacy. 2018; 28(3): 188
[Pubmed] | [DOI]
157 Acting on non-communicable diseases in low- and middle-income tropical countries
Majid Ezzati,Jonathan Pearson-Stuttard,James E. Bennett,Colin D. Mathers
Nature. 2018;
[Pubmed] | [DOI]
158 Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study
Iain M. Carey,Julia A. Critchley,Stephen DeWilde,Tess Harris,Fay J. Hosking,Derek G. Cook
Diabetes Care. 2018; 41(3): 513
[Pubmed] | [DOI]
159 Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis
Alaa Badawi,Russanthy Velummailum,Seung Gwan Ryoo,Arrani Senthinathan,Sahar Yaghoubi,Denitsa Vasileva,Emma Ostermeier,Mikayla Plishka,Marcel Soosaipillai,Paul Arora,Pierre Roques
PLOS ONE. 2018; 13(7): e0200200
[Pubmed] | [DOI]
160 Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine Learning Applications in Type 1 Diabetes (Preprint)
Ashenafi Zebene Woldaregay,Eirik Ĺrsand,Taxiarchis Botsis,David Albers,Lena Mamykina,Gunnar Hartvigsen
Journal of Medical Internet Research. 2018;
[Pubmed] | [DOI]
161 Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-?B
Sura Al Zoubi,Jianmin Chen,Catherine Murphy,Lukas Martin,Fausto Chiazza,Debora Collotta,Muhammad M. Yaqoob,Massimo Collino,Christoph Thiemermann
Frontiers in Immunology. 2018; 9
[Pubmed] | [DOI]
162 Epidemiology and Immune Pathogenesis of Viral Sepsis
Gu-Lung Lin,Joseph P. McGinley,Simon B. Drysdale,Andrew J. Pollard
Frontiers in Immunology. 2018; 9
[Pubmed] | [DOI]
163 Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
Julia A. Critchley,Iain M. Carey,Tess Harris,Stephen DeWilde,Fay J. Hosking,Derek G. Cook
Diabetes Care. 2018; 41(10): 2127
[Pubmed] | [DOI]
164 Severe ischemic cytomegalovirus proctocolitis with multiple perforation
Reuban Toby D’cruz,Cheryl Chien-Li Lau,Thomas Paulraj Thamboo
Archives of Virology. 2018;
[Pubmed] | [DOI]
165 Fulminant mucormycosis of maxillary sinuses after dental extraction inpatients with uncontrolled diabetic: Two case reports
N. Gholinejad Ghadi,Z. Seifi,T. Shokohi,S.R. Aghili,M. Nikkhah,L. Vahedi Larijani,M. Ghasemi,I. Haghani
Journal de Mycologie Médicale. 2018;
[Pubmed] | [DOI]
166 Multi-centre prospective internal and external evaluation of the Brompton Harefield Infection Score (BHIS)
Melissa Rochon,Julian WE Jarman,Joseph Gabriel,Lisa Butcher,Carlos Morais,Martin Still,Ishtiaq Ahmed,Mario Petrou,Richard Trimlett,Anthony DeSouza,Rashmi Yadav,Shahzad G Raja
Journal of Infection Prevention. 2018; 19(2): 74
[Pubmed] | [DOI]
167 Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Christoph A. Thaiss,Maayan Levy,Inna Grosheva,Danping Zheng,Eliran Soffer,Eran Blacher,Sofia Braverman,Anouk C. Tengeler,Oren Barak,Maya Elazar,Rotem Ben-Zeev,Dana Lehavi-Regev,Meirav N. Katz,Meirav Pevsner-Fischer,Arieh Gertler,Zamir Halpern,Alon Harmelin,Suhail Aamar,Patricia Serradas,Alexandra Grosfeld,Hagit Shapiro,Benjamin Geiger,Eran Elinav
Science. 2018; 359(6382): 1376
[Pubmed] | [DOI]
168 Incidence of Cellulitis in Lower Extremity Burns
Joseph N. Batac,Roger L. Simpson,Catherine J. Sinnott,Michael P. Catanzaro,Laurence T. Glickman
Annals of Plastic Surgery. 2018; : 1
[Pubmed] | [DOI]
169 Perioperative Considerations to Reduce Infection Risk in Primary Total Hip and Knee Arthroplasty
Michael J. DeRogatis,Annalisse M. Mahon,Patrick Lee,Paul S. Issack
JBJS Reviews. 2018; 6(4): e8
[Pubmed] | [DOI]
Yusra Fatima,Maimoona Mustafa
Journal of Evolution of Medical and Dental Sciences. 2017; 6(85): 5924
[Pubmed] | [DOI]
171 Osteonecrosis of the jaw unrelated to medication or radiotherapy
Yusuf Gadiwalla,Vinod Patel
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2017;
[Pubmed] | [DOI]
172 Mice with Streptozotocin-Induced Hyperglycemia are Susceptible to Invasive Enteric Bacterial Infection
Hemanta Koley,Poushali Ghosh,Ritam Sinha,Soma Mitra,Priyadarshini Mukherjee,Debaki Ranjan Howlader,Chandrima Chaki,Dhrubajyoti Nag
Japanese Journal of Infectious Diseases. 2017; 70(1): 111
[Pubmed] | [DOI]
173 Glycated Hemoglobin and Risk of Sternal Wound Infection After Isolated Coronary Surgery
Giuseppe Gatti,Andrea Perrotti,Daniel Reichart,Luca Maschietto,Francesco Onorati,Sidney Chocron,Magnus Dalén,Peter Svenarud,Giuseppe Faggian,Giuseppe Santarpino,Theodor Fischlein,Aniello Pappalardo,Daniele Maselli,Carmelo Dominici,Saverio Nardella,Antonino S. Rubino,Marisa De Feo,Francesco Santini,Francesco Nicolini,Riccardo Gherli,Giovanni Mariscalco,Tuomas Tauriainen,Eeva-Maija Kinnunen,Vito G. Ruggieri,Matteo Saccocci,Fausto Biancari
Circulation Journal. 2017; 81(1): 36
[Pubmed] | [DOI]
174 Effects of glycosylated hemoglobin levels on neutrophilic phagocytic functions
Michelle Shodja Mary,Knutsen Raymond,Cao Jeffrey,Oda Keiji,Beeson.W. Lawrence,Fraser. E. Gary,Knutsen Synnove
Journal of Diabetes and Endocrinology. 2017; 8(2): 9
[Pubmed] | [DOI]
175 Outcomes following repair of incarcerated and strangulated ventral hernias with or without synthetic mesh
Sameh Hany Emile,Hesham Elgendy,Ahmad Sakr,Waleed Ahmed Gado,Ahmed Aly Abdelmawla,Mahmoud Abdelnaby,Alaa Magdy
World Journal of Emergency Surgery. 2017; 12(1)
[Pubmed] | [DOI]
176 Dysbiosis of urinary microbiota is positively correlated with Type 2 diabetes mellitus
Fengping Liu,Zongxin Ling,Yonghong Xiao,Longxian Lv,Qing Yang,Baohong Wang,Haifeng Lu,Li Zheng,Ping Jiang,Wei Wang,Lanjuan Li
Oncotarget. 2017; 8(3): 3798
[Pubmed] | [DOI]
177 High prevalence of candiduria due to non-albicans Candida species among diabetic patients: A matter of concern?
Alireza Esmailzadeh,Hossein Zarrinfar,AbdolMajid Fata,Tanuka Sen
Journal of Clinical Laboratory Analysis. 2017; : e22343
[Pubmed] | [DOI]
178 Diabetes and Sepsis: Risk, Recurrence, and Ruination
Lynn M. Frydrych,Fatemeh Fattahi,Katherine He,Peter A. Ward,Matthew J. Delano
Frontiers in Endocrinology. 2017; 8
[Pubmed] | [DOI]
179 Whole-genome expression analyses of type 2 diabetes in human skin reveal altered immune function and burden of infection
Chun Wu,Xiaopan Chen,Jing Shu,Chun-Ting Lee
Oncotarget. 2017; 8(21): 34601
[Pubmed] | [DOI]
180 Analysis of factors influencing survival in patients with severe acute pancreatitis
Yeon Ji Kim,Dae Bum Kim,Woo Chul Chung,Ji Min Lee,Gun Jung Youn,Yun Duk Jung,Sooa Choi,Jung Hwan Oh
Scandinavian Journal of Gastroenterology. 2017; : 1
[Pubmed] | [DOI]
181 Alterations of Urinary Microbiota in Type 2 Diabetes Mellitus with Hypertension and/or Hyperlipidemia
Fengping Liu,Zongxin Ling,Yonghong Xiao,Qing Yang,Baohong Wang,Li Zheng,Ping Jiang,Lanjuan Li,Wei Wang
Frontiers in Physiology. 2017; 8
[Pubmed] | [DOI]
182 Chemical Constituents and Biological Activities of Essential Oils of Hydnora africana Thumb Used to Treat Associated Infections and Diseases in South Africa
Olubunmi Wintola,Anthony Afolayan
Applied Sciences. 2017; 7(5): 443
[Pubmed] | [DOI]
183 Not Only Glycaemic But Also Other Metabolic Factors Affect T Regulatory Cell Counts and Proinflammatory Cytokine Levels in Women with Type 1 Diabetes
Katerina Stechova,Jana Sklenarova-Labikova,Tereza Kratzerova,Pavlina Pithova,Dominik Filipp
Journal of Diabetes Research. 2017; 2017: 1
[Pubmed] | [DOI]
184 Rhinocerebral Mucormycosis in a Patient with Diabetes Type 1 Presenting as Ptosis and Facial Palsy Report from Alborz Hospital of Karaj from Iran
Leila Kheirkhah
International Clinical Pathology Journal. 2017; 5(2)
[Pubmed] | [DOI]
185 Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results
Michael R. Gold,Johan D. Aasbo,Mikhael F. El-Chami,Mark Niebauer,John Herre,Jordan M. Prutkin,Bradley P. Knight,Steven Kutalek,Kevin Hsu,Raul Weiss,Eric Bass,Michael Husby,Timothy M. Stivland,Martin C. Burke
Heart Rhythm. 2017;
[Pubmed] | [DOI]
186 Microbial Degradation of Forensic Samples of Biological Origin: Potential Threat to Human DNA Typing
Hirak Ranjan Dash,Surajit Das
Molecular Biotechnology. 2017;
[Pubmed] | [DOI]
187 Impact of diabetes on free flap surgery of the head and neck: A NSQIP analysis
Jacob S. Brady,Aparna Govindan,Meghan M. Crippen,Andrey Filimonov,Jean Anderson Eloy,Soly Baredes,Richard Chan Woo Park
Microsurgery. 2017;
[Pubmed] | [DOI]
188 Diabetes mellitus y su impacto en la etiopatogenia de la sepsis
Limberth Machado-Villarroel,Mabel Montano-Candia,Diamanti Abraham Dimakis-Ramírez
Acta Médica Grupo Ángeles. 2017; 15(3): 207
[Pubmed] | [DOI]
189 Risk factors for early invasive fungal disease in critically ill patients
Ceva Pitoyo,Dita Aditianingsih,Cleopas Rumende
Indian Journal of Critical Care Medicine. 2016; 20(11): 633
[Pubmed] | [DOI]
190 Gangrenous Leg in a Patient With Diabetes on MDP Bone Scintigraphy
Osayande Evbuomwan,Olusegun Akinwale Ayeni,Shireen Dhoodhat,Mboyo Di Tamba Vangu
Clinical Nuclear Medicine. 2016; 41(5): 428
[Pubmed] | [DOI]
191 Hyperglycemia Impairs Neutrophil-Mediated Bacterial Clearance in Mice Infected with the Lyme Disease Pathogen
Ashkan Javid,Nataliya Zlotnikov,Helena Petrošová,Tian Tian Tang,Yang Zhang,Anil K. Bansal,Rhodaba Ebady,Maitry Parikh,Mijhgan Ahmed,Chunxiang Sun,Susan Newbigging,Yae Ram Kim,Marianna Santana Sosa,Michael Glogauer,Tara J. Moriarty,Brian Stevenson
PLOS ONE. 2016; 11(6): e0158019
[Pubmed] | [DOI]
Amit Ray,Purba Haldar,Prakas Kumar Mandal,Indranil Chakraborty,Sushil Ranjan Ghoshal,Amitava Sarkar
Journal of Evolution of Medical and Dental Sciences. 2016; 5(99): 7267
[Pubmed] | [DOI]
193 Comparison of a Simple Nutrition Screening Tool (SNST) Compared with Subjective Global Assessment (SGA) in Body Mass Index (BMI) Assessments of Type 2 Diabetic Patients Validation of SNST Versus BMI in T2 Diabetes
Banun B.R. Rohimah,S. Sugiarto,Ari A.P. Probandari,Budiyanti B.W. Wiboworini
Pakistan Journal of Nutrition. 2016; 15(5): 412
[Pubmed] | [DOI]
194 Topical Prostaglandin E Analog Restores Defective Dendritic Cell–Mediated Th17 Host Defense Against Methicillin-Resistant Staphylococcus Aureus in the Skin of Diabetic Mice
Naiara N. Dejani,Stephanie L. Brandt,Annie Pińeros,Nicole L. Glosson-Byers,Sue Wang,Young Min Son,Alexandra I. Medeiros,C. Henrique Serezani
Diabetes. 2016; 65(12): 3718
[Pubmed] | [DOI]
195 High absolute risk of severe infections among Indigenous adults in rural northern Australia is amplified by diabetes – A 7 year follow up study
Ming Li,Robyn McDermott
Journal of Diabetes and its Complications. 2016;
[Pubmed] | [DOI]
196 Necrotizing Fasciitis in a 68-year old patient with Insulin-treated Steroid Diabetes
Christina Voulgari,Eleftheria Alexaki,Stavroula Chini,Sophia Vogiaki,Irene Gamatsi,Stamata Pagoni
Journal of Clinical and Translational Endocrinology: Case Reports. 2016;
[Pubmed] | [DOI]
197 Respiratory Burst Process in Diabetic Children
Anahita Sanaei Dashti,Soodabeh Taheri,Reza Jouybar,Mohammadreza Hashemnia,Abdollah Karimi,Seyed Abdolmajid Shoja
Iranian Journal of Pediatrics. 2016; In Press(In Press)
[Pubmed] | [DOI]
198 Magnesium Therapy Prevents Senescence with the Reversal of Diabetes and Alzheimer’s Disease
Ian James Martins
Health. 2016; 08(07): 694
[Pubmed] | [DOI]
199 Immune and vascular dysfunction in diabetic wound healing
A.S. Ahmed,E.L. Antonsen
Journal of Wound Care. 2016; 25(Sup7): S35
[Pubmed] | [DOI]
200 Urinary infection due to Balantioides coli: a rare accidental zoonotic disease in an addicted and diabetic young female in Iran
Abdolghayyoum Movahhedi Roudi,Saman Soleimanpour,Seyedeh Sara Raeisalsadati,Ali Babaei
JMM Case Reports. 2016; 3(1)
[Pubmed] | [DOI]
201 The Effect of Short-Term Hyperglycemia on the Innate Immune System
Nagham Jafar,Hawa Edriss,Kenneth Nugent
The American Journal of the Medical Sciences. 2016; 351(2): 201
[Pubmed] | [DOI]
202 Preliminary Phytochemical Screening and Biological Activities ofBulbine abyssinicaUsed in the Folk Medicine in the Eastern Cape Province, South Africa
Cromwell Mwiti Kibiti,Anthony Jide Afolayan
Evidence-Based Complementary and Alternative Medicine. 2015; 2015: 1
[Pubmed] | [DOI]
203 Leukotriene B4–mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetes
Luciano Ribeiro Filgueiras,Stephanie L. Brandt,Soujuan Wang,Zhuo Wang,David L. Morris,Carmella Evans-Molina,Raghavendra G. Mirmira,Sonia Jancar,C. Henrique Serezani
Science Signaling. 2015; 8(361): ra10
[Pubmed] | [DOI]
204 Temporal trends and factors associated with pediatric hospitalizations with respiratory infection
Yingxue Chen,Jianfang Liu,Elaine Larson
Journal of Asthma. 2015; : 1
[Pubmed] | [DOI]
205 Long-Term Immunogenicity and Safety of a Conventional Influenza Vaccine in Patients with Type 2 Diabetes
Yu Bin Seo,Ji Hyeon Baek,Jacob Lee,Joon Young Song,Jin Soo Lee,Hee Jin Cheong,Woo Joo Kim,S. A. Plotkin
Clinical and Vaccine Immunology. 2015; 22(11): 1160
[Pubmed] | [DOI]
206 Antibiotic Use Is Not a Risk Factor of Infection by Extended-Spectrum Beta-Lactamase Producing Bacteria in Dr. Soetomo Hospital Surabaya
Microbiology Indonesia. 2015; 9(4): 150
[Pubmed] | [DOI]
207 Neutralization of Mitochondrial Superoxide by Superoxide Dismutase 2 Promotes Bacterial Clearance and Regulates Phagocyte Numbers in Zebrafish
E. M. Peterman,C. Sullivan,M. F. Goody,I. Rodriguez-Nunez,J. A. Yoder,C. H. Kim,B. A. McCormick
Infection and Immunity. 2015; 83(1): 430
[Pubmed] | [DOI]
208 Discovery of novel 1,3,5-triazine-thiazolidine-2,4-diones as dipeptidyl peptidase-4 inhibitors with antibacterial activity targeting the S1 pocket for the treatment of type 2 diabetes
Jitendra Kumar Srivastava,Pragya Dubey,Saumya Singh,Hans Raj Bhat,Mukesh Kumar Kumawat,Udaya Pratap Singh
RSC Adv.. 2015; 5(19): 14095
[Pubmed] | [DOI]
209 Diabetes
Hagen Bomberg,Christine Kubulus,Franka List,Noemi Albert,Kathrin Schmitt,Stefan Gräber,Paul Kessler,Thorsten Steinfeldt,Thomas Standl,André Gottschalk,Stefan P. Wirtz,Gerald Burgard,Peter Geiger,Claudia D. Spies,Thomas Volk
Regional Anesthesia and Pain Medicine. 2015; 40(1): 16
[Pubmed] | [DOI]
210 The Skin Remodeling in Type 1 Diabetes and Insulin Resistance Animal Models
Physiological Research. 2015; : 875
[Pubmed] | [DOI]
211 Individuality, phenotypic differentiation, dormancy and ‘persistence’ in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology
Douglas Kell,Marnie Potgieter,Etheresia Pretorius
F1000Research. 2015; 4: 179
[Pubmed] | [DOI]
212 Individuality, phenotypic differentiation, dormancy and ‘persistence’ in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology
Douglas Kell,Marnie Potgieter,Etheresia Pretorius
F1000Research. 2015; 4: 179
[Pubmed] | [DOI]
213 Disseminated Mucormycosis in an Adolescent with Newly Diagnosed Diabetes Mellitus
Michael C. McCrory,Blake A. Moore,Thomas A. Nakagawa,Laurence B. Givner,Donald R. Jason,Elizabeth L. Palavecino,Samuel J. Ajizian
The Pediatric Infectious Disease Journal. 2014; 33(10): 1094
[Pubmed] | [DOI]
214 Neutrophil granulocyte functional status and expression of apoptosis markers in children with type 1 diabetes
Lyudmila Yurćevna Barycheva,Natalya Eduardovna Erdni-Goryaeva,Galina Alekseevna Alexandrovich
Diabetes mellitus. 2014; 17(3): 77
[Pubmed] | [DOI]
215 Population-Based Cohort Study of Anti-Infective Medication Use before and after the Onset of Type 1 Diabetes in Children and Adolescents
Soulmaz Fazeli Farsani,Patrick C. Souverein,Marja M. J. van der Vorst,Catherijne A. J. Knibbe,Anthonius de Boer,Aukje K. Mantel-Teeuwisse
Antimicrobial Agents and Chemotherapy. 2014; 58(8): 4666
[Pubmed] | [DOI]
216 Complication Rates Following Elective Lumbar Fusion in Patients With Diabetes
Nicholas S. Golinvaux,Arya G. Varthi,Daniel D. Bohl,Bryce A. Basques,Jonathan N. Grauer
Spine. 2014; 39(21): 1809
[Pubmed] | [DOI]
217 Palliative Wound Care, Part 2
Kevin R. Emmons,Barbara Dale,Cathy Crouch
Home Healthcare Nurse. 2014; 32(4): 210
[Pubmed] | [DOI]
218 Self-reported diabetes and mortality in a prospective Chinese elderly cohort study in Hong Kong
Chen Shen,C. Mary Schooling,Wai Man Chan,Siu Yin Lee,Gabriel M. Leung,Tai Hing Lam
Preventive Medicine. 2014;
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
    Materials and Me...
    Diabetes Mellitu...
    Major Infections...
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded6450    
    Comments [Add]    
    Cited by others 218    

Recommend this journal